| Year |
Citation |
Score |
| 2024 |
Velloza J, Poovan N, Meisner A, Ndlovu N, Ndimande-Khoza N, Grabow C, Zwane P, Mbele S, Molefe M, Donnell D, Baeten JM, Hosek S, Celum C, Delany-Moretlwe S. Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trial. The Lancet. Hiv. PMID 39681126 DOI: 10.1016/S2352-3018(24)00268-6 |
0.418 |
|
| 2024 |
Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, ... ... Baeten JM, et al. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. The New England Journal of Medicine. PMID 39602624 DOI: 10.1056/NEJMoa2411858 |
0.533 |
|
| 2024 |
Peebles K, Matrajt L, Baeten JM, Palanee-Phillips T, Brown ER. Understanding the sources of efficacy dilution in a trial of a monthly dapivirine vaginal ring for HIV-1 prevention. International Journal of Std & Aids. 9564624241300199. PMID 39591433 DOI: 10.1177/09564624241300199 |
0.616 |
|
| 2024 |
Mounzer K, Slim J, Ramgopal M, Hedgcock M, Bloch M, Santana J, Mendes I, Guo Y, Arora P, Montezuma-Rusca JM, Sklar P, Baeten JM, Segal-Maurer S. Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex Human Immunodeficiency Virus Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 39589133 DOI: 10.1093/cid/ciae522 |
0.339 |
|
| 2024 |
Husnik MJ, Heffron R, Hughes JP, Richardson B, van der Straten A, Palanee-Phillips T, Soto-Torres L, Singh D, Mirembe BG, Livant E, Gaffoor Z, Mansoor LE, Siva SS, Dadabhai S, Kiweewa FM, ... Baeten JM, et al. Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence. Aids and Behavior. PMID 39158801 DOI: 10.1007/s10461-024-04463-3 |
0.676 |
|
| 2024 |
Morrison S, Batting J, Wanga V, Beesham I, Deese J, Hofmeyr GJ, Kasaro MP, Louw C, Morrison C, Mugo NR, Palanee-Phillips T, Pleaner M, Reddy K, Scoville CW, Smit J, ... ... Baeten JM, et al. True and false positive HIV point of care test results in a prospective multinational study of at-risk African women: implications for large-scale repeat HIV testing in HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 39085989 DOI: 10.1097/QAI.0000000000003497 |
0.596 |
|
| 2024 |
Njuguna N, Akolo C, Anzala O, Baeten JM, Heffron R, Mugo NR, Bateganya M. Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic. Current Hiv/Aids Reports. PMID 39052142 DOI: 10.1007/s11904-024-00703-2 |
0.613 |
|
| 2024 |
Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, Gill K, Harkoo I, Jaggernath M, Kigozi G, Kiwanuka N, Kotze P, Lebina L, Louw CE, Malahleha M, ... ... Baeten JM, et al. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. The New England Journal of Medicine. PMID 39046157 DOI: 10.1056/NEJMoa2407001 |
0.598 |
|
| 2024 |
Wohl DA, Spinner CD, Flamm J, Hare CB, Doblecki-Lewis S, Ruane PJ, Molina JM, Mills A, Brinson C, Ramgopal M, Clarke A, Crofoot G, Martorell C, Carter C, Cox S, ... ... Baeten JM, et al. HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial. The Lancet. Hiv. PMID 39008999 DOI: 10.1016/S2352-3018(24)00130-9 |
0.443 |
|
| 2024 |
Mugambi ML, Odhiambo BO, Dollah A, Marwa MM, Nyakina J, Kinuthia J, Baeten JM, Weiner BJ, John-Stewart G, Barnabas RV, Hauber B. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment. Journal of the International Aids Society. e26301. PMID 38965978 DOI: 10.1002/jia2.26301 |
0.577 |
|
| 2024 |
Matthews LT, Jaggernath M, Kriel Y, Smith PM, Haberer JE, Baeten JM, Hendrix CW, Ware NC, Moodley P, Pillay M, Bennett K, Bassler J, Psaros C, Hurwitz KE, Bangsberg DR, et al. Oral PrEP uptake, adherence, and persistence during periconception periods among women in South Africa: an intervention study. Aids (London, England). PMID 38752557 DOI: 10.1097/QAD.0000000000003925 |
0.439 |
|
| 2024 |
Ortblad KF, Kuo AP, Mogere P, Roche SD, Kiptinness C, Wairimu N, Gakuo S, Baeten JM, Ngure K. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya. Bmc Health Services Research. 24: 618. PMID 38730398 DOI: 10.1186/s12913-024-10995-0 |
0.598 |
|
| 2024 |
Wu L, Kinuthia J, Anderson PL, Baeten JM, Dettinger JC, Gandhi M, Gomez L, John-Stewart G, Marwa MM, Ngumbau N, Otieno F, Omondi P, Odhiambo B, Watoyi S, Pintye J. Drug concentrations in hair and dried blood spots as PrEP adherence metrics during pregnancy and postpartum. The Journal of Infectious Diseases. PMID 38700101 DOI: 10.1093/infdis/jiae208 |
0.401 |
|
| 2024 |
Rousseau E, Sikkema KJ, Julies RF, Mazer K, O'Malley G, Heffron R, Morton JF, Johnson R, Celum C, Baeten JM, Bekker LG. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa. Journal of the International Aids Society. 27: e26254. PMID 38695101 DOI: 10.1002/jia2.26254 |
0.634 |
|
| 2024 |
Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, et al. HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 38484128 DOI: 10.1093/cid/ciae143 |
0.55 |
|
| 2024 |
Zewdie KB, Ngure K, Mwangi M, Mwangi D, Maina S, Etyang L, Maina G, Ogello V, Owidi E, Mugo NR, Baeten JM, Mugwanya KK. Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation. Journal of the International Aids Society. 27: e26222. PMID 38446643 DOI: 10.1002/jia2.26222 |
0.388 |
|
| 2024 |
Marrazzo J, Tao L, Becker M, Leech AA, Taylor AW, Ussery F, Kiragu M, Reza-Paul S, Myers J, Bekker LG, Yang J, Carter C, de Boer M, Das M, Baeten JM, et al. HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women. Jama. PMID 38427359 DOI: 10.1001/jama.2024.0464 |
0.523 |
|
| 2024 |
Ngumbau NM, Neary J, Wagner AD, Abuna F, Ochieng B, Dettinger JC, Gómez L, Marwa MM, Watoyi S, Nzove E, Pintye J, Baeten JM, Kinuthia J, John-Stewart G. Cofactors of Partner HIV Self-testing and Oral PrEP Acceptance Among Pregnant Women at High Risk of HIV in Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). 95: 238-245. PMID 38408215 DOI: 10.1097/QAI.0000000000003355 |
0.614 |
|
| 2024 |
Haberer JE, Oware K, Juma L, Nyerere B, Momanyi V, Odoyo J, Garrison L, Bhagat J, Musinguzi N, Baeten JM, Siegler A, Bukusi EA. My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya. Journal of the International Aids Society. 27: e26217. PMID 38379132 DOI: 10.1002/jia2.26217 |
0.517 |
|
| 2024 |
Eron JJ, Little SJ, Crofoot G, Cook P, Ruane PJ, Jayaweera D, VanderVeen LA, DeJesus E, Zheng Y, Mills A, Huang H, Waldman SE, Ramgopal M, Gorgos L, Collins SE, ... Baeten JM, et al. Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study. The Lancet. Hiv. PMID 38307098 DOI: 10.1016/S2352-3018(23)00293-X |
0.491 |
|
| 2023 |
Stalter RM, Dong TQ, Hendrix CW, Palanee-Phillips T, van der Straten A, Hillier SL, Kiweewa FM, Mgodi NM, Marzinke MA, Bekker LG, Soto-Torres L, Baeten JM, Brown ER. Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women using the Dapivirine Vaginal Ring. The Journal of Infectious Diseases. PMID 38099506 DOI: 10.1093/infdis/jiad550 |
0.555 |
|
| 2023 |
Vera M, Bukusi E, Achieng P, Aketch H, Araka E, Baeten JM, Beima-Sofie K, John-Stewart G, Kohler PK, Mugambi ML, Nyerere B, Odoyo J, Omom C, Omondi C, Ortblad KF, et al. : Experiences With Pharmacy-Based PrEP Delivery Among Adolescent Girls and Young Women in Kisumu, Kenya. Journal of the International Association of Providers of Aids Care. 22: 23259582231215882. PMID 37997351 DOI: 10.1177/23259582231215882 |
0.384 |
|
| 2023 |
Ndimande-Khoza MN, Katz AWK, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V, Morton J, Johnson R, Bekker LG, Bukusi EA, Baeten J, Celum C, van der Straten A, Roberts ST. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa. Plos One. 18: e0292529. PMID 37963171 DOI: 10.1371/journal.pone.0292529 |
0.336 |
|
| 2023 |
Wairimu N, Malen RC, Reedy AM, Mogere P, Njeru I, Culquichicón C, McGowan M, Gao F, Baeten JM, Ngure K, Ortblad KF. Peer PrEP referral + HIV self-test delivery for PrEP initiation among young Kenyan women: study protocol for a hybrid cluster-randomized controlled trial. Trials. 24: 705. PMID 37925450 DOI: 10.1186/s13063-023-07734-x |
0.642 |
|
| 2023 |
Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabiito C, Bekker LG, Siziba B, ... ... Baeten JM, et al. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. The Lancet. Hiv. PMID 37898146 DOI: 10.1016/S2352-3018(23)00227-8 |
0.387 |
|
| 2023 |
Hurwitz KE, Isehunwa OO, Hendrickson KR, Jaggernath M, Kriel Y, Smith PM, Mathenjwa M, Bennett K, Psaros C, Baeten JM, Bangsberg DR, Haberer JE, Smit JA, Matthews LT. Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women. Frontiers in Reproductive Health. 5: 1263422. PMID 37860779 DOI: 10.3389/frph.2023.1263422 |
0.546 |
|
| 2023 |
Parikh UM, Penrose KJ, Heaps AL, Sethi R, Goetz BJ, Szydlo D, Chandran U, Palanee-Phillips T, Mgodi NM, Baeten JM, Mellors JW. HIV Drug Resistance Assessment among Women who Seroconverted during the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 37732881 DOI: 10.1097/QAI.0000000000003308 |
0.488 |
|
| 2023 |
Sahu M, Bayer CJ, Roberts DA, van Rooyen H, van Heerden A, Shahmanesh M, Asiimwe S, Sausi K, Sithole N, Ying R, Rao DW, Krows ML, Shapiro AE, Baeten JM, Celum C, et al. Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study. Plos Global Public Health. 3: e0000610. PMID 37669249 DOI: 10.1371/journal.pgph.0000610 |
0.475 |
|
| 2023 |
Celum C, Seidman D, Travill D, Dehlendorf C, Gumede S, Zewdie K, Wilson W, Morton JF, Baeten JM, Donnell D, Delany-Moretlwe S. A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial. Journal of the International Aids Society. 26: e26154. PMID 37634942 DOI: 10.1002/jia2.26154 |
0.515 |
|
| 2023 |
Avihingsanon A, Lu H, Leong CL, Hung CC, Koenig E, Kiertiburanakul S, Lee MP, Supparatpinyo K, Zhang F, Rahman S, D'Antoni ML, Wang H, Hindman JT, Martin H, Baeten JM, et al. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial. The Lancet. Hiv. PMID 37494942 DOI: 10.1016/S2352-3018(23)00151-0 |
0.495 |
|
| 2023 |
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial. The Lancet. Hiv. PMID 37451297 DOI: 10.1016/S2352-3018(23)00113-3 |
0.549 |
|
| 2023 |
Mugo NR, Mudhune V, Heffron R, Thomas KK, McLellan-Lemal E, Njoroge B, Peacock S, O'Connor SM, Nyagol B, Ouma E, Ridzon R, Wiener J, Isoherranen N, Erikson DW, Ouattara LA, ... ... Baeten JM, et al. Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya. Frontiers in Reproductive Health. 5: 1118030. PMID 37383290 DOI: 10.3389/frph.2023.1118030 |
0.656 |
|
| 2023 |
Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women. Journal of the International Aids Society. 26: e26118. PMID 37363917 DOI: 10.1002/jia2.26118 |
0.319 |
|
| 2023 |
Musinguzi N, Ngure K, Bukusi EA, Mugo NR, Baeten JM, Anderson PL, Haberer JE. Performance of Multiple Adherence Measures for pre-exposure Prophylaxis (PrEP) Among Young Women in Kenya. Aids and Behavior. PMID 37351684 DOI: 10.1007/s10461-023-04111-2 |
0.426 |
|
| 2023 |
Beesham I, Milford C, Smit J, Joseph Davey DL, Baeten JM, Heffron R, Beksinska M, Mansoor LE. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa. Bmc Public Health. 23: 1210. PMID 37349816 DOI: 10.1186/s12889-023-16139-z |
0.598 |
|
| 2023 |
Rousseau E, Wu L, Heffron R, Baeten JM, Celum CL, Travill D, Delany-Moretlwe S, Bekker LG, Bukusi E, Omollo V, van der Straten A, O'Malley G, Haberer JE, Morton JF, Johnson RE, et al. Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa. Frontiers in Reproductive Health. 5: 1073103. PMID 37325240 DOI: 10.3389/frph.2023.1073103 |
0.56 |
|
| 2023 |
Ortblad KF, Bardon AR, Mogere P, Kiptinness C, Gakuo S, Mbaire S, Thomas KK, Mugo NR, Baeten JM, Ngure K. Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial. Jama Network Open. 6: e2318590. PMID 37318803 DOI: 10.1001/jamanetworkopen.2023.18590 |
0.584 |
|
| 2023 |
Ortblad KF, Mogere P, Omollo V, Kuo AP, Asewe M, Gakuo S, Roche S, Mugambi M, Mugambi ML, Stergachis A, Odoyo J, Bukusi EA, Ngure K, Baeten JM. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation. Journal of the International Aids Society. 26: e26131. PMID 37306128 DOI: 10.1002/jia2.26131 |
0.597 |
|
| 2023 |
Oware K, Adiema L, Rono B, Violette LR, McClelland RS, Donnell D, Scoville CW, Odoyo J, Baeten JM, Bukusi E, Stewart J. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention. Bmc Women's Health. 23: 296. PMID 37270546 DOI: 10.1186/s12905-023-02413-0 |
0.548 |
|
| 2023 |
Sax PE, Arribas JR, Orkin C, Lazzarin A, Pozniak A, DeJesus E, Maggiolo F, Stellbrink HJ, Yazdanpanah Y, Acosta R, Huang H, Hindman JT, Martin H, Baeten JM, Wohl D. Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials. Eclinicalmedicine. 59: 101991. PMID 37200995 DOI: 10.1016/j.eclinm.2023.101991 |
0.325 |
|
| 2023 |
Omollo V, Asewe M, Mogere P, Maina G, Kuo AP, Odoyo J, Oware K, Baeten JM, Kohler P, Owens T, Bukusi EA, Ngure K, Ortblad KF. The fidelity of a pharmacy-based oral HIV pre-exposure prophylaxis delivery model in Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 37079900 DOI: 10.1097/QAI.0000000000003208 |
0.451 |
|
| 2023 |
Nakambale HN, Roche SD, Mogere P, Omollo V, Kuo AP, Stergachis A, Baeten JM, Bukusi E, Ngure K, Mugambi ML, Ortblad KF. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data. Frontiers in Reproductive Health. 5: 1023568. PMID 36895656 DOI: 10.3389/frph.2023.1023568 |
0.455 |
|
| 2023 |
Delany-Moretlwe S, Mgodi N, Bekker LG, Baeten JM, Li C, Donnell D, Agyei Y, Lennon D, Rose SM, Mokgatle M, Kassim S, Mukaka S, Adeyeye A, Celum C. High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial. Sexually Transmitted Infections. PMID 36889914 DOI: 10.1136/sextrans-2022-055696 |
0.575 |
|
| 2023 |
Velloza J, Roche SD, Owidi EJ, Irungu EM, Dollah A, Kwach B, Thuo NB, Morton JF, Mugo N, Bukusi EA, O'Malley G, Ngure K, Baeten JM, Mugwanya KK. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya. Journal of the International Aids Society. 26: e26055. PMID 36739603 DOI: 10.1002/jia2.26055 |
0.598 |
|
| 2023 |
Brown BP, Feng C, Tanko RF, Jaumdally SZ, Bunjun R, Dabee S, Happel AU, Gasper M, Nyangahu DD, Onono M, Nair G, Palanee-Phillips T, Scoville CW, Heller K, Baeten JM, et al. Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial. Nature Communications. 14: 499. PMID 36717556 DOI: 10.1038/s41467-023-36002-4 |
0.531 |
|
| 2022 |
Gupta SK, Berhe M, Crofoot G, Benson P, Ramgopal M, Sims J, McDonald C, Ruane P, Sanchez WE, Scribner A, Liu SY, VanderVeen LA, Dvory-Sobol H, Rhee MS, Baeten JM, et al. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. The Lancet. Hiv. 10: e15-e23. PMID 36566079 DOI: 10.1016/S2352-3018(22)00291-0 |
0.533 |
|
| 2022 |
Triplett NS, Roberts ST, Hartmann M, Wagner D, Reddy KR, Mathebula F, Tolley EE, Baeten JM, Palanee-Phillips T, Montgomery ET. Examining Associations Between Mental Health, IPV Exposure, HIV Risk Behaviors, and PrEP Use in South African Women: An Analysis of Data from the Charisma Study. Aids and Behavior. PMID 36459264 DOI: 10.1007/s10461-022-03936-7 |
0.431 |
|
| 2022 |
Barnabas RV, Szpiro AA, Ntinga X, Mugambi ML, van Rooyen H, Bruce A, Joseph P, Ngubane T, Krows ML, Schaafsma TT, Zhao T, Tanser F, Baeten JM, Celum C, van Heerden A. Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: a randomised controlled trial. The Lancet. Hiv. 9: e848-e856. PMID 36335976 DOI: 10.1016/S2352-3018(22)00254-5 |
0.378 |
|
| 2022 |
Kuo AP, Roche SD, Mugambi ML, Pintye J, Baeten JM, Bukusi E, Ngure K, Stergachis A, Ortblad KF. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review. Journal of the International Aids Society. 25: e26027. PMID 36285619 DOI: 10.1002/jia2.26027 |
0.444 |
|
| 2022 |
Heffron R, Muwonge TR, Boyer J, Matovu F, Zia Y, Bagaya M, Ssebuliba T, Morrison S, Bambia F, Nsubuga R, Badaru J, Stein G, Mugwanya KK, Wyatt C, Baeten JM, et al. Bone mineral density, nutrient intake, and physical activity among young women from Uganda. Archives of Osteoporosis. 17: 134. PMID 36216962 DOI: 10.1007/s11657-022-01155-0 |
0.49 |
|
| 2022 |
Peebles K, Brown ER, Hendrix CW, Palanee-Phillips T, van der Straten A, Harkoo I, Reddy K, Mirembe BG, Jeenarain N, Hillier SL, Baeten JM, Barnabas RV. Dapivirine ring HIV-1 prevention effectiveness for women engaged in vaginal and anal intercourse: insights from mathematical modeling. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 36184755 DOI: 10.1097/QAI.0000000000003110 |
0.578 |
|
| 2022 |
Omollo V, Roche SD, Mogaka F, Odoyo J, Barnabee G, Bukusi EA, Katz AWK, Morton J, Johnson R, Baeten JM, Celum C, O'Malley G. Provider-client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya. Sexual and Reproductive Health Matters. 30: 2095707. PMID 36169648 DOI: 10.1080/26410397.2022.2095707 |
0.301 |
|
| 2022 |
Garcia-Cremades M, Hendrix CW, Jayachandran P, Strydom N, Jarlsberg L, Grant R, Celum CL, Martin M, Baeten JM, Marrazzo J, Anderson P, Choopanya K, Vanichseni S, Glidden DV, Savic RM. Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis. Pharmaceutics. 14. PMID 36145549 DOI: 10.3390/pharmaceutics14091801 |
0.591 |
|
| 2022 |
Beesham I, Parikh UM, Mellors JW, Joseph Davey DL, Heffron R, Palanee-Phillips T, Bosman SL, Beksinska M, Smit J, Ahmed K, Makkan H, Selepe P, Louw C, Kotze P, Hofmeyr GJ, ... ... Baeten JM, et al. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. Journal of Acquired Immune Deficiency Syndromes (1999). 91: 130-137. PMID 36094478 DOI: 10.1097/QAI.0000000000003027 |
0.777 |
|
| 2022 |
Heffron R, Muwonge TR, Thomas KK, Nambi F, Nakabugo L, Kibuuka J, Thomas D, Feutz E, Meisner A, Ware NC, Wyatt MA, Simoni JM, Katz IT, Kadama H, Baeten JM, et al. PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial. Eclinicalmedicine. 52: 101611. PMID 35990584 DOI: 10.1016/j.eclinm.2022.101611 |
0.789 |
|
| 2022 |
Beesham I, Mansoor LE, Joseph Davey DL, Palanee-Phillips T, Smit J, Ahmed K, Selepe P, Louw C, Singata-Madliki M, Kotze P, Heffron R, Parikh UM, Wiesner L, Rees H, Baeten JM, et al. Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial. Journal of Acquired Immune Deficiency Syndromes (1999). 91: 26-30. PMID 35972853 DOI: 10.1097/QAI.0000000000003023 |
0.739 |
|
| 2022 |
Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, et al. Initiating Intramuscular Depot Medroxyprogesterone Acetate (DMPA-IM) Increases Frequencies of Th17-like Human Immunodeficiency Virus (HIV) Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35941737 DOI: 10.1093/cid/ciac284 |
0.727 |
|
| 2022 |
Katz IT, Ngure K, Kamolloh K, Ogello V, Okombo M, Thuo NB, Owino E, Garrison LE, Lee YS, Nardell MF, Anyacheblu C, Bukusi E, Mugo N, Baeten JM, Haberer JE. Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya. Aids and Behavior. PMID 35930203 DOI: 10.1007/s10461-022-03748-9 |
0.473 |
|
| 2022 |
Ogello V, Ngure K, Thuo N, Burns B, Rono B, Oware K, Kiptiness C, Mugo N, Bukusi E, Garrison L, Baeten JM, Haberer JE. "Yes, I'm reminded, but it doesn't mean I'm taking them": Experiences with Short Message Service Reminder Use in Real-time Monitoring of HIV PrEP among Young Women in Kenya. Aids and Behavior. PMID 35907142 DOI: 10.1007/s10461-022-03744-z |
0.312 |
|
| 2022 |
Njuguna N, Mugo N, Anzala O, Mureithi M, Irungu E, Wamicwe J, Baeten JM, Heffron R. An empiric tool to identify Kenyans living with HIV who will have unsuppressed viremia 18 months following treatment initiation to guide differentiated care models. Plos One. 17: e0271520. PMID 35853007 DOI: 10.1371/journal.pone.0271520 |
0.607 |
|
| 2022 |
Musinguzi N, Pyra M, Bukusi EA, Mugo NR, Baeten JM, Haberer JE. Trajectories of Oral PrEP Adherence Among Young Kenyan Women: Implications for Promoting Effective PrEP Use. Aids and Behavior. PMID 35841463 DOI: 10.1007/s10461-022-03753-y |
0.377 |
|
| 2022 |
Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, ... ... Baeten JM, et al. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project. Journal of the International Aids Society. 25: e25962. PMID 35822945 DOI: 10.1002/jia2.25962 |
0.743 |
|
| 2022 |
Ngure K, Ortblad KF, Mogere P, Bardon AR, Thomas KK, Mangale D, Kiptinness C, Gakuo S, Mbaire S, Nyokabi J, Mugo NR, Baeten JM. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial. The Lancet. Hiv. 9: e464-e473. PMID 35777410 DOI: 10.1016/S2352-3018(22)00126-6 |
0.569 |
|
| 2022 |
Mwongeli N, Wagner AD, Dettinger JC, Pintye J, Brown Trinidad S, Awuor M, Kimemia G, Ngure K, Heffron RA, Baeten JM, Mugo N, Bukusi EA, Kinuthia J, Kelley MC, John-Stewart GC, et al. " Healthcare Worker Perspectives on Using pre-Exposure Prophylaxis (PrEP) During Pregnancy and Postpartum in Kenya. Journal of the International Association of Providers of Aids Care. 21: 23259582221111068. PMID 35776525 DOI: 10.1177/23259582221111068 |
0.774 |
|
| 2022 |
Velloza J, Mujugira A, Muwonge T, Boyer J, Nampewo O, Badaru J, Ssebuliba T, Stalter RM, Stein G, Baeten JM, Celum C, Heffron R. A novel "HIV salience and Perception" scale is associated with PrEP dispensing and adherence among adolescent girls and young women in Kampala, Uganda. Aids and Behavior. PMID 35776250 DOI: 10.1007/s10461-022-03762-x |
0.704 |
|
| 2022 |
Hunidzarira P, Brown ER, Chirenje ZM, Hillier SL, Marrazzo JM, Palanee-Phillips T, Kiweewa FM, Baeten JM. Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials. The Journal of Infectious Diseases. PMID 35763413 DOI: 10.1093/infdis/jiac269 |
0.621 |
|
| 2022 |
Stewart J, Bukusi E, Sesay FA, Oware K, Donnell D, Soge OO, Celum C, Odoyo J, Kwena ZA, Scoville CW, Violette LR, Morrison S, Simoni J, McClelland RS, Barnabas R, ... ... Baeten JM, et al. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial. Trials. 23: 495. PMID 35710444 DOI: 10.1186/s13063-022-06458-8 |
0.536 |
|
| 2022 |
Palanee-Phillips T, Rees HV, Heller KB, Ahmed K, Batting J, Beesham I, Heffron R, Justman J, Makkan H, Mastro TD, Morrison SA, Mugo N, Nair G, Kiarie J, Philip NM, ... ... Baeten JM, et al. High HIV incidence among young women in South Africa: Data from a large prospective study. Plos One. 17: e0269317. PMID 35657948 DOI: 10.1371/journal.pone.0269317 |
0.802 |
|
| 2022 |
Cespedes M, Das M, Hojilla JC, Blumenthal J, Mounzer K, Ramgopal M, Hodge T, Torres TS, Peterson C, Shibase S, Elliott A, Demidont AC, Callaghan L, Watson CC, Carter C, ... ... Baeten JM, et al. Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP). Plos One. 17: e0267780. PMID 35657826 DOI: 10.1371/journal.pone.0267780 |
0.528 |
|
| 2022 |
Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, Margot NA, Dvory-Sobol H, Hyland RH, Brainard DM, Rhee MS, ... Baeten JM, et al. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection. The New England Journal of Medicine. 386: 1793-1803. PMID 35544387 DOI: 10.1056/NEJMoa2115542 |
0.462 |
|
| 2022 |
Katz AWK, Balán IC, Reddy K, Etima J, Weber K, Tauya T, Atujuna M, Scheckter R, Ngure K, Soto-Torres L, Mgodi N, Palanee-Phillips T, Baeten JM, van der Straten A. Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring. Aids and Behavior. PMID 35536519 DOI: 10.1007/s10461-022-03663-z |
0.493 |
|
| 2022 |
Zewdie K, Kiptinness C, Ngure K, Kipkurui N, Wairimu N, Ambiyo F, Mugo NR, Baeten JM, Mugwanya KK. Targeted implementation of HIV self-testing increases testing uptake among partners of index persons known to have HIV in Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 35476826 DOI: 10.1097/QAI.0000000000003003 |
0.623 |
|
| 2022 |
Garcia-Cremades M, Vučićević K, Hendrix CW, Jayachandran P, Jarlsberg L, Grant R, Celum CL, Martin M, Baeten JM, Marrazzo J, Anderson P, Choopanya K, Vanichseni S, Glidden DV, Savic RM. Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35474481 DOI: 10.1093/cid/ciac313 |
0.53 |
|
| 2022 |
Muwonge TR, Nsubuga R, Ware NC, Wyatt MA, Pisarski E, Kamusiime B, Kasiita V, Nalukwago GK, Brown C, Nakyanzi A, Bagaya M, Bambia F, Ssebuliba T, Katabira E, Kyambadde P, ... Baeten JM, et al. Health Care Worker Perspectives of HIV Pre-exposure Prophylaxis Service Delivery in Central Uganda. Frontiers in Public Health. 10: 658826. PMID 35444979 DOI: 10.3389/fpubh.2022.658826 |
0.611 |
|
| 2022 |
Velloza J, Poovan N, Ndlovu N, Khoza N, Morton JF, Omony J, Mkwanazi E, Grabow C, Donnell D, Munthali R, Baeten JM, Hosek S, Celum C, Delany-Moretlwe S. Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial. Plos One. 17: e0266665. PMID 35417485 DOI: 10.1371/journal.pone.0266665 |
0.587 |
|
| 2022 |
Montgomery ET, Roberts ST, Reddy K, Tolley EE, Hartmann M, Mathebula F, Wagner LD, Lanham M, Wilcher R, Browne EN, Baeten JM, Palanee-Phillips T. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 90: 425-433. PMID 35416797 DOI: 10.1097/QAI.0000000000002991 |
0.454 |
|
| 2022 |
Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, Morton JF, Johnson R, Celum C, Baeten JM, O'Malley G. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study. Bmc Health Services Research. 22: 422. PMID 35354456 DOI: 10.1186/s12913-022-07742-8 |
0.41 |
|
| 2022 |
Browne EN, Brown ER, Palanee-Phillips T, Reddy K, Naidoo L, Jeenarain N, Nair G, Husnik MJ, Singh D, Scheckter R, Soto-Torres L, Baeten JM, van der Straten A. Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 35344520 DOI: 10.1097/QAI.0000000000002990 |
0.496 |
|
| 2022 |
Kwena ZA, Bukusi EA, Turan JM, Darbes L, Farquhar C, Makokha C, Baeten JM. Effects of the Waya Intervention on Marital Satisfaction and HIV Risk Behaviors in Western Kenya: A Pre-Post Study Design. Archives of Sexual Behavior. PMID 35338399 DOI: 10.1007/s10508-021-02180-9 |
0.538 |
|
| 2022 |
Tanko RF, Bunjun R, Dabee S, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Harryparsad R, Happel AU, Gamieldien H, Qumbelo Y, Sinkala M, Scoville CW, Heller K, Baeten JM, et al. The Effect Of Contraception On Genital Cytokines In Women Randomized To Copper Intrauterine Device, Intramuscular Depot Medroxyprogesterone Acetate Or Levonorgestrel Implant. The Journal of Infectious Diseases. PMID 35263421 DOI: 10.1093/infdis/jiac084 |
0.637 |
|
| 2022 |
Mujugira A, Kasiita V, Bagaya M, Nakyanzi A, Bambia F, Nampewo O, Kamusiime B, Mugisha J, Nalumansi A, Twesigye CC, Muwonge TR, Baeten JM, Wyatt MA, Tsai AC, Ware NC, et al. "You are not a man": a multi-method study of trans stigma and risk of HIV and sexually transmitted infections among trans men in Uganda. Journal of the International Aids Society. 24: e25860. PMID 34965322 DOI: 10.1002/jia2.25860 |
0.526 |
|
| 2022 |
Mujugira A, Nakyanzi A, Nabaggala MS, Muwonge TR, Ssebuliba T, Bagaya M, Nampewo O, Sapiri O, Nyanzi KR, Bambia F, Nsubuga R, Serwadda DM, Ware NC, Baeten JM, Haberer JE. Effect of HIV Self-Testing on PrEP Adherence Among Gender-Diverse Sex Workers in Uganda: A Randomized Trial. Journal of Acquired Immune Deficiency Syndromes (1999). 89: 381-389. PMID 34954718 DOI: 10.1097/QAI.0000000000002895 |
0.586 |
|
| 2021 |
Ngure K, Thuo N, Ogello V, Kiptinness C, Kamolloh K, Burns BFO, Mugo NR, Bukusi EA, Garrison L, Baeten JM, Haberer JE. Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study. Frontiers in Reproductive Health. 3: 637869. PMID 36304002 DOI: 10.3389/frph.2021.637869 |
0.593 |
|
| 2021 |
Dabee S, Tanko RF, Brown BP, Bunjun R, Balle C, Feng C, Konstantinus IN, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Gill K, Baeten JM, Bekker LG, Passmore JS, et al. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis. Frontiers in Immunology. 12: 760504. PMID 34956191 DOI: 10.3389/fimmu.2021.760504 |
0.528 |
|
| 2021 |
Mugambi ML, Baeten JM, Kinuthia J, Hauber B, Weiner BJ, John-Stewart G, Barnabas RV. Design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settings in western Kenya: a mixed-methods study protocol. Bmj Open. 11: e052311. PMID 34911715 DOI: 10.1136/bmjopen-2021-052311 |
0.563 |
|
| 2021 |
Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM. Incidence of herpes simplex virus type 2 infection among African women using depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a nested randomized trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34910143 DOI: 10.1093/cid/ciab1027 |
0.526 |
|
| 2021 |
Mugwanya KK, Matemo D, Scoville CW, Beima-Sofie KM, Meisner A, Onyango D, Mugambi M, Feutz E, Grabow C, Barnabas R, Weiner B, Baeten JM, Kinuthia J. Integrating PrEP delivery in public health family planning clinics: a protocol for a pragmatic stepped wedge cluster randomized trial in Kenya. Implementation Science Communications. 2: 135. PMID 34895357 DOI: 10.1186/s43058-021-00228-4 |
0.558 |
|
| 2021 |
Irungu EM, Mugwanya KK, Mugo NR, Bukusi EA, Donnell D, Odoyo J, Wamoni E, Peacock S, Morton JF, Ngure K, Mugambi M, Mukui I, O'Malley G, Baeten JM. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. The Lancet. Global Health. 9: e1730-e1739. PMID 34798031 DOI: 10.1016/S2214-109X(21)00391-0 |
0.517 |
|
| 2021 |
Parikh UM, Penrose KJ, Heaps AL, Halvas EK, Goetz BJ, Gordon KC, Hardesty R, Sethi R, Schwarzmann W, Szydlo DW, Husnik MJ, Chandran U, Palanee-Phillips T, Baeten JM, Mellors JW, et al. HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. Journal of the International Aids Society. 24: e25833. PMID 34762770 DOI: 10.1002/jia2.25833 |
0.478 |
|
| 2021 |
Stewart J, Baeten JM. HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity. Nature Reviews. Urology. PMID 34697493 DOI: 10.1038/s41585-021-00527-4 |
0.604 |
|
| 2021 |
Rousseau E, Katz AWK, O'Rourke S, Bekker LG, Delany-Moretlwe S, Bukusi E, Travill D, Omollo V, Morton JF, O'Malley G, Haberer JE, Heffron R, Johnson R, Celum C, Baeten JM, et al. Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya. Plos One. 16: e0258542. PMID 34648589 DOI: 10.1371/journal.pone.0258542 |
0.588 |
|
| 2021 |
Montgomery ET, Roberts ST, Reddy K, Tolley E, Hartmann M, Wilson E, Mathebula F, Wagner LD, Zissette S, Lanham M, Wilcher R, Baeten JM, Palanee-Phillips T. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study. Aids and Behavior. PMID 34546473 DOI: 10.1007/s10461-021-03434-2 |
0.428 |
|
| 2021 |
Irungu EM, Odoyo J, Wamoni E, Bukusi EA, Mugo NR, Ngure K, Morton JF, Mugwanya KK, Baeten JM, O'Malley G. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics. Journal of the International Aids Society. 24: e25799. PMID 34496148 DOI: 10.1002/jia2.25799 |
0.436 |
|
| 2021 |
Mujugira A, Nakyanzi A, Kasiita V, Kamusiime B, Nalukwago GK, Nalumansi A, Twesigye CC, Muwonge TR, Baeten JM, Wyatt MA, Haberer JE, Ware NC. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda. Journal of the International Aids Society. 24: e25782. PMID 34473405 DOI: 10.1002/jia2.25782 |
0.529 |
|
| 2021 |
Rousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R, Baeten JM, O'Malley G. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. Bmc Health Services Research. 21: 888. PMID 34454505 DOI: 10.1186/s12913-021-06920-4 |
0.617 |
|
| 2021 |
Ngure K, Mugo NR, Bukusi EA, Kiptinness C, Oware K, Gakuo S, Musinguzi N, Pyra M, Garrison L, Baeten JM, Haberer JE. Pills, injections, rings or implants? PrEP formulation preferences of PrEP-experienced African women for HIV prevention. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 34446676 DOI: 10.1097/QAI.0000000000002793 |
0.517 |
|
| 2021 |
Peebles K, Mugwanya KK, Irungu E, Odoyo J, Wamoni E, Morton JF, Ngure K, Bukusi EA, Mugo NR, Masyuko S, Mukui I, Baeten JM, Barnabas RV. Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in Kenya's public sector. Bmc Health Services Research. 21: 823. PMID 34399736 DOI: 10.1186/s12913-021-06832-3 |
0.404 |
|
| 2021 |
Ogbuagu O, Ruane PJ, Podzamczer D, Salazar LC, Henry K, Asmuth DM, Wohl D, Gilson R, Shao Y, Ebrahimi R, Cox S, Kintu A, Carter C, Das M, Baeten JM, et al. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Hiv. 8: e397-e407. PMID 34197772 DOI: 10.1016/S2352-3018(21)00071-0 |
0.402 |
|
| 2021 |
Richert-Spuhler LE, Mar CM, Shinde P, Wu F, Hong T, Greene E, Hou S, Thomas K, Gottardo R, Mugo N, de Bruyn G, Celum C, Baeten JM, Lingappa JR, Lund JM, et al. genetic variants modify regulatory and conventional T cell phenotypes and functions. Cell Reports. Medicine. 2: 100322. PMID 34195685 DOI: 10.1016/j.xcrm.2021.100322 |
0.343 |
|
| 2021 |
Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, ... ... Baeten JM, et al. Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization. Aids (London, England). PMID 34172672 DOI: 10.1097/QAD.0000000000003004 |
0.47 |
|
| 2021 |
Ngure K, Trinidad SB, Beima-Sofie K, Kinuthia J, Matemo D, Kimemia G, Njoroge A, Achiro L, Pintye J, Mugo NR, Bukusi EA, Baeten JM, Heffron R, John-Stewart G, Kelley MC. Perceived Social Influences on Women's Decisions to use Medications not Studied in Pregnancy. A Qualitative Ethical Analysis of Preexposure Prophylaxis Implementation Research in Kenya. Journal of Empirical Research On Human Research Ethics : Jerhre. 16: 225-237. PMID 34133231 DOI: 10.1177/15562646211012296 |
0.568 |
|
| 2021 |
Donnell D, Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, ... ... Baeten JM, et al. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study. The Lancet. Hiv. PMID 34126052 DOI: 10.1016/S2352-3018(21)00048-5 |
0.731 |
|
| 2021 |
Husnik MJ, Brown ER, Dadabhai SS, Gaffoor Z, Jeenarain N, Kiweewa FM, Livant E, Mansoor LE, Mirembe BG, Palanee-Phillips T, Singh D, Siva S, Soto-Torres L, van der Straten A, Baeten JM, et al. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention. Aids and Behavior. PMID 34117592 DOI: 10.1007/s10461-021-03231-x |
0.372 |
|
| 2021 |
Glidden DV, Das M, Dunn DT, Ebrahimi R, Zhao Y, Stirrup OT, Baeten JM, Anderson PL. Using the adherence-efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trial. Journal of the International Aids Society. 24: e25744. PMID 34021709 DOI: 10.1002/jia2.25744 |
0.485 |
|
| 2021 |
Gao Y, Yuan T, Zhan Y, Qian HZ, Sun Y, Zheng W, Fu L, Liang B, Zhu Z, Ouyang L, Liu M, Fitzpatrick T, Wu Z, Meng X, Baeten JM, et al. Association between medical male circumcision and HIV risk compensation among heterosexual men: a systematic review and meta-analysis. The Lancet. Global Health. PMID 33939956 DOI: 10.1016/S2214-109X(21)00102-9 |
0.531 |
|
| 2021 |
Beksinska M, Issema R, Beesham I, Lalbahadur T, Thomas K, Morrison C, Hofmeyr GJ, Steyn PS, Mugo N, Palanee-Phillips T, Ahmed K, Nair G, Baeten JM, Smit J. Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial. Eclinicalmedicine. 34: 100800. PMID 33898953 DOI: 10.1016/j.eclinm.2021.100800 |
0.319 |
|
| 2021 |
Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa. Bmc Women's Health. 21: 175. PMID 33892693 DOI: 10.1186/s12905-021-01321-5 |
0.49 |
|
| 2021 |
Omollo V, Bukusi EA, Kidoguchi L, Mogaka F, Odoyo JB, Celum C, Morton J, Johnson R, Baeten JM. A pilot evaluation of expedited partner treatment and partner HIV self-testing among adolescent girls and young women diagnosed with Chlamydia trachomatis and Neisseria gonorrhoeae in Kisumu, Kenya. Sexually Transmitted Diseases. PMID 33859147 DOI: 10.1097/OLQ.0000000000001430 |
0.539 |
|
| 2021 |
Wanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB, Morton JF, Bukusi EA, Celum C, Baeten JM, Barnabas RV. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. Plos One. 16: e0249625. PMID 33857195 DOI: 10.1371/journal.pone.0249625 |
0.347 |
|
| 2021 |
Roche SD, Wairimu N, Mogere P, Kamolloh K, Odoyo J, Kwena ZA, Bukusi EA, Ngure K, Baeten JM, Ortblad KF. Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives. Aids and Behavior. PMID 33826022 DOI: 10.1007/s10461-021-03229-5 |
0.496 |
|
| 2021 |
Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, Seyama L, Woeber K, Harkoo I, Reddy K, Tembo T, Mutero P, Tauya T, Chitukuta M, Gati Mirembe B, ... ... Baeten JM, et al. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. Aids and Behavior. PMID 33713213 DOI: 10.1007/s10461-021-03205-z |
0.329 |
|
| 2021 |
Nickolas TL, Barasch J, Mugwanya KK, Branch AD, Heffron R, Wanga V, Mugo NR, Ronald A, Celum C, Donnell D, Baeten JM, Wyatt CM. Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis. Aids (London, England). PMID 33710023 DOI: 10.1097/QAD.0000000000002865 |
0.567 |
|
| 2021 |
Haberer JE, Bukusi EA, Mugo NR, Pyra M, Kiptinness C, Oware K, Garrison LE, Thomas KK, Musinguzi N, Morrison S, Anderson PL, Ngure K, Baeten JM. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial. The Lancet. Hiv. 8: e130-e137. PMID 33662265 DOI: 10.1016/S2352-3018(20)30307-6 |
0.428 |
|
| 2021 |
Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet. Hiv. 8: e87-e95. PMID 33539762 DOI: 10.1016/S2352-3018(20)30304-0 |
0.561 |
|
| 2021 |
Stalter RM, Baeten JM, Donnell D, Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Mugo N, Mujugira A, Marzinke M, Hendrix C, Gandhi M. Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 72: 486-489. PMID 33527128 DOI: 10.1093/cid/ciaa785 |
0.482 |
|
| 2021 |
Ongolly FK, Dolla A, Ngure K, Irungu EM, Odoyo J, Wamoni E, Peebles K, Mugwanya K, Mugo NR, Bukusi EA, Morton J, Baeten JM, O'Malley G. "I just decided to stop: " Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33492024 DOI: 10.1097/QAI.0000000000002625 |
0.39 |
|
| 2021 |
Mugo N, Eckert LO, Odero L, Gakuo S, Ngure K, Celum C, Baeten JM, Barnabas RV, Wald A. Antibody responses to prophylactic quadrivalent human papillomavirus vaccine at 48 months among HIV-infected girls and boys ages 9-14 in Kenya, Africa. Vaccine. PMID 33485644 DOI: 10.1016/j.vaccine.2020.12.020 |
0.349 |
|
| 2020 |
Stewart J, Baeten JM. Preventing Disease, Not Sex-Harm Reduction, HIV Preexposure Prophylaxis, and Sexually Transmitted Infections. Jama Network Open. 3: e2031102. PMID 33355671 DOI: 10.1001/jamanetworkopen.2020.31102 |
0.498 |
|
| 2020 |
Celum CL, Gill K, Morton JF, Stein G, Myers L, Thomas KK, McConnell M, van der Straten A, Baeten JM, Duyver M, Mendel E, Naidoo K, Dallimore J, Wiesner L, Bekker LG. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial. Journal of the International Aids Society. 23: e25636. PMID 33247553 DOI: 10.1002/jia2.25636 |
0.446 |
|
| 2020 |
Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Philips T, Marzinke MA, Bekker LG, Soto-Torres L, Hillier SL, Baeten JM. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. Journal of the International Aids Society. 23: e25634. PMID 33206462 DOI: 10.1002/jia2.25634 |
0.543 |
|
| 2020 |
Ortblad KF, Mogere P, Roche S, Kamolloh K, Odoyo J, Irungu E, Mugo NR, Pintye J, Baeten JM, Bukusi E, Ngure K. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation. Bmc Health Services Research. 20: 1034. PMID 33176785 DOI: 10.1186/s12913-020-05898-9 |
0.407 |
|
| 2020 |
Musinguzi N, Kidoguchi L, Mugo NR, Ngure K, Katabira E, Celum CL, Baeten JM, Heffron R, Haberer JE. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy. Bmc Public Health. 20: 1621. PMID 33115478 DOI: 10.1186/s12889-020-09712-3 |
0.783 |
|
| 2020 |
Muwonge TR, Nsubuga R, Brown C, Nakyanzi A, Bagaya M, Bambia F, Katabira E, Kyambadde P, Baeten JM, Heffron R, Celum C, Mujugira A, Haberer JE. Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda. Plos One. 15: e0241399. PMID 33112907 DOI: 10.1371/journal.pone.0241399 |
0.65 |
|
| 2020 |
Beesham I, Heffron R, Evans S, Baeten JM, Smit J, Beksinska M, Mansoor LE. Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial. Aids and Behavior. PMID 33106996 DOI: 10.1007/s10461-020-03072-0 |
0.73 |
|
| 2020 |
Mujugira A, Baeten JM, Hodges-Mameletzis I, Haberer JE. Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen. Drugs. PMID 33040323 DOI: 10.1007/s40265-020-01419-4 |
0.465 |
|
| 2020 |
Hughes SM, Levy CN, Calienes FL, Stekler JD, Pandey U, Vojtech L, Berard AR, Birse K, Noël-Romas L, Richardson B, Golden JB, Cartwright M, Collier AC, Stevens CE, Curlin ME, ... ... Baeten JM, et al. Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection. Cell Reports. Medicine. 1: 100096. PMID 33015651 DOI: 10.1016/j.xcrm.2020.100096 |
0.469 |
|
| 2020 |
Ngure K, Velloza J, Patel RC, Mugo NR, Bukusi EA, Haberer JE, Odoyo J, Celum C, Baeten JM, Heffron R. Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships. International Journal of Std & Aids. 956462420951501. PMID 32998640 DOI: 10.1177/0956462420951501 |
0.679 |
|
| 2020 |
Wanga V, Mackelprang RD, Thomas KK, Donnell D, Cohen CR, Mugo NR, Bukusi EA, de Bruyn G, Irungu E, Celum C, Baeten JM, Lingappa JR. Bacterial vaginosis and risk of HIV infection in the context of CD101 gene variation. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32976203 DOI: 10.1097/QAI.0000000000002505 |
0.52 |
|
| 2020 |
Barnabas RV, Szpiro AA, van Rooyen H, Asiimwe S, Pillay D, Ware NC, Schaafsma TT, Krows ML, van Heerden A, Joseph P, Shahmanesh M, Wyatt MA, Sausi K, Turyamureeba B, Sithole N, ... ... Baeten JM, et al. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial. The Lancet. Global Health. 8: e1305-e1315. PMID 32971053 DOI: 10.1016/S2214-109X(20)30313-2 |
0.639 |
|
| 2020 |
McMahan VM, Frank N, Buckler S, Violette LR, Baeten JM, Banta-Green CJ, Barnabas RV, Simoni J, Stekler JD. Protocol Development for HMU! (HIV Prevention for Methamphetamine Users), a Study of Peer Navigation and Text Messaging to Promote Pre-Exposure Prophylaxis Adherence and Persistence Among People Who Use Methamphetamine: Qualitative Focus Group and Interview Study. Jmir Formative Research. 4: e18118. PMID 32924952 DOI: 10.2196/18118 |
0.594 |
|
| 2020 |
Balán IC, Giguere R, Lentz C, Kutner BA, Kajura-Manyindo C, Byogero R, Asiimwe FB, Makala Y, Jambaya J, Khanyile N, Chetty D, Soto-Torres L, Mayo A, Mgodi NM, Palanee-Phillips T, ... Baeten JM, et al. Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study). Aids and Behavior. PMID 32833192 DOI: 10.1007/S10461-020-03011-Z |
0.457 |
|
| 2020 |
Wanga V, Omollo V, Bukusi EA, Odoyo JB, Morton JF, Kidoguchi L, Johnson R, Hughes JP, Celum C, Baeten JM. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya. Journal of the International Aids Society. 23: e25561. PMID 32820597 DOI: 10.1002/Jia2.25561 |
0.667 |
|
| 2020 |
Pintye J, Davey DLJ, Wagner AD, John-Stewart G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Groves AK, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre JA, ... ... Baeten JM, et al. Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework. The Lancet. Hiv. 7: e582-e592. PMID 32763221 DOI: 10.1016/S2352-3018(20)30102-8 |
0.768 |
|
| 2020 |
Peebles K, Palanee-Phillips T, Balkus JE, Beesham I, Makkan H, Deese J, Smit J, Heffron R, Morrison CS, Philip NM, Malahleha M, Kasaro M, Naidoo Y, Nielson T, Reddy K, ... ... Baeten JM, et al. Age-specific risk scores do not improve HIV-1 prediction among women in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32701820 DOI: 10.1097/Qai.0000000000002436 |
0.652 |
|
| 2020 |
Stalter R, Mugwanya K, Thomas K, Donnell D, Mujugira A, Ngure K, Celum C, Kidoguchi L, Bukusi E, Baeten J, Heffron R. Sexual behaviors following PrEP discontinuation among HIV serodiscordant couples in Kenya and Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32658130 DOI: 10.1097/Qai.0000000000002434 |
0.78 |
|
| 2020 |
Barnabas RV, van Heerden A, McConnell M, Szpiro AA, Krows ML, Schaafsma TT, Ngubane T, Nxele RB, Joseph P, Baeten JM, Celum CL, van Rooyen H. Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study. Journal of the International Aids Society. 23: e25519. PMID 32589342 DOI: 10.1002/Jia2.25519 |
0.609 |
|
| 2020 |
Bochner AF, Baeten JM, Secor WE, van Dam GJ, Szpiro AA, Njenga SM, Corstjens PLAM, Newsam A, Mugo NR, Celum C, Mujugira A, McClelland RS, Barnabas RV. Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis. Journal of the International Aids Society. 23: e25534. PMID 32585078 DOI: 10.1002/Jia2.25534 |
0.598 |
|
| 2020 |
Onono M, Nanda K, Heller KB, Taylor D, Yacobson I, Heffron R, Kasaro MP, Louw CE, Nhlabasti Z, Palanee-Phillips T, Smit J, Wakhungu I, Gichangi PB, Mugo NR, Morrison C, ... Baeten JM, et al. Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception. Contraception: X. 2: 100026. PMID 32577615 DOI: 10.1016/j.conx.2020.100026 |
0.484 |
|
| 2020 |
Stalter RM, Baeten JM, Donnell D, Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Mugo N, Mujugira A, Marzinke M, Hendrix C, Gandhi M. Urine Tenofovir Levels Measured by a Novel Immunoassay Predict HIV Protection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32569370 DOI: 10.1093/Cid/Ciaa785 |
0.643 |
|
| 2020 |
Wagner AD, Kinuthia J, Dettinger J, Mwongeli N, GÓmez L, Watoyi S, Drake AL, Abuna F, Pintye J, Ochieng B, Odinga D, John-Stewart G, Baeten JM. Challenges of discrepant HIV tests in pregnant women in the PrEP era - to treat or not to treat? The Journal of Infectious Diseases. PMID 32561928 DOI: 10.1093/Infdis/Jiaa343 |
0.683 |
|
| 2020 |
Ortblad KF, Baeten JM. HIV service delivery innovation in high-prevalence settings. The Lancet. Hiv. 7: e378-e379. PMID 32504569 DOI: 10.1016/S2352-3018(20)30112-0 |
0.565 |
|
| 2020 |
Morton JF, Myers L, Gill K, Bekker LG, Stein G, Thomas KK, Duyver M, van der Straten A, McConnell M, Aunger R, Curtis V, de Witt Huberts J, Van Damme L, Baeten JM, Celum C. Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa. Gates Open Research. 4: 29. PMID 32411946 DOI: 10.12688/gatesopenres.13103.1 |
0.397 |
|
| 2020 |
Irungu EM, Baeten JM. PrEP rollout in Africa: status and opportunity. Nature Medicine. 26: 655-664. PMID 32405065 DOI: 10.1038/S41591-020-0872-X |
0.653 |
|
| 2020 |
Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, ... ... Baeten JM, et al. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial. Journal of the International Aids Society. 23: e25491. PMID 32396700 DOI: 10.1002/Jia2.25491 |
0.818 |
|
| 2020 |
Morrison CS, Hofmeyr GJ, Thomas KK, Rees H, Philip N, Palanee-Phillips T, Nanda K, Nair G, Onono M, Mastro TD, Lind M, Heffron R, Edward V, Deese J, Beksinska M, ... ... Baeten J, et al. Effects of depot medroxyprogesterone acetate, copper intrauterine devices, and levonorgestrel implants on early HIV disease progression. Aids Research and Human Retroviruses. PMID 32394723 DOI: 10.1089/Aid.2020.0015 |
0.733 |
|
| 2020 |
Celum C, Baeten J. PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options Cell Host & Microbe. 27: 502-506. PMID 32272075 DOI: 10.1016/J.Chom.2020.03.020 |
0.665 |
|
| 2020 |
Drain P, Ngure K, Mugo N, Spinelli M, Chatterjee P, Bacchetti P, Glidden D, Baeten J, Gandhi M. Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial. Jmir Research Protocols. 9: e15029. PMID 32238341 DOI: 10.2196/15029 |
0.417 |
|
| 2020 |
Drake AL, Begnel E, Pintye J, Kinuthia J, Wagner AD, Rothschild CW, Otieno F, Kemunto V, Baeten JM, John-Stewart G. The Utility of SMS to Report Male Partner HIV Self-testing Outcomes Among Women Seeking Reproductive Health Services in Kenya: Cohort Study. Jmir Mhealth and Uhealth. 8: e15281. PMID 32209530 DOI: 10.2196/15281 |
0.523 |
|
| 2020 |
Begnel ER, Escudero J, Mugambi M, Mugwanya K, Kinuthia J, Beima-Sofie K, Dettinger JC, Baeten JM, John-Stewart G, Pintye J. High pre-exposure prophylaxis awareness and willingness to pay for pre-exposure prophylaxis among young adults in Western Kenya: results from a population-based survey. International Journal of Std & Aids. 956462420912141. PMID 32208816 DOI: 10.1177/0956462420912141 |
0.437 |
|
| 2020 |
Irungu EM, Ngure K, Mugwanya KK, Awuor M, Dollah A, Ongolly F, Mugo N, Bukusi E, Wamoni E, Odoyo J, Morton JF, Barnabee G, Mukui I, Baeten JM, O'Malley G, et al. "Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?" the condom quandary among PrEP users and health care providers in Kenya. Aids Care. 1-9. PMID 32207327 DOI: 10.1080/09540121.2020.1744507 |
0.569 |
|
| 2020 |
Oyaro P, Kwena Z, Bukusi EA, Baeten JM. Is HIV self-testing a strategy to increase repeat testing among pregnant and postpartum women? A pilot mixed methods study. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32195747 DOI: 10.1097/Qai.0000000000002347 |
0.675 |
|
| 2020 |
Stewart J, Bukusi E, Celum C, Delany-Moretlwe S, Baeten JM. Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention. Aids (London, England). 34: 651-658. PMID 32167988 DOI: 10.1097/Qad.0000000000002472 |
0.521 |
|
| 2020 |
McMahan VM, McCanta L, Tran D, Herrera L, Viquez L, Swanson F, Crutsinger-Perry B, Baeten JM, Katz A, Stekler JD. Administrative and Related Barriers to Covering the Costs of PrEP at a Safety-Net Clinic in Seattle, WA. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32152636 DOI: 10.1093/Cid/Ciaa187 |
0.482 |
|
| 2020 |
Ngure K, Ongolly F, Dolla A, Awour M, Mugwanya KK, Irungu E, Mugo N, Bukusi EA, Morton J, Odoyo J, Wamoni E, Barnabee G, Peebles K, O'Malley G, Baeten JM, et al. "I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya. Journal of the International Aids Society. 23: e25466. PMID 32144888 DOI: 10.1002/Jia2.25466 |
0.655 |
|
| 2020 |
Pintye J, Rogers Z, Kinuthia J, Mugwanya KK, Abuna F, Lagat H, Sila J, Kemunto V, Baeten JM, John-Stewart G, Unger JA. Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya. Global Health, Science and Practice. PMID 32139420 DOI: 10.9745/Ghsp-D-19-00347 |
0.47 |
|
| 2020 |
Pintye J, Kinuthia J, Abuna F, Mugwanya K, Lagat H, Dettinger JC, Odinga D, Sila J, Anderson PL, John-Stewart G, Baeten JM. Frequency and predictors of tenofovir-diphosphate detection among young Kenyan women in a real-world pre-exposure prophylaxis implementation program. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32109293 DOI: 10.1093/Cid/Ciaa181 |
0.459 |
|
| 2020 |
Shahrir S, Crothers K, McGinnis K, Chan G, Baeten JM, Wilson S, Butt AA, Pisani MA, Baldassarri S, Justice A, Williams EC. Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV. Progress in Cardiovascular Diseases. PMID 31987807 DOI: 10.1016/J.Pcad.2020.01.003 |
0.543 |
|
| 2020 |
Wanga V, Baeten JM, Bukusi EA, Mugo NR, Asiimwe S, Ngure K, Mujugira A, Muwonge T, Odoyo JB, Haberer JE, Celum C, Heffron R. Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa. Aids and Behavior. PMID 31925607 DOI: 10.1007/S10461-019-02773-5 |
0.787 |
|
| 2020 |
Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre J, Moodley D, et al. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? Journal of the International Aids Society. 23: e25426. PMID 31912985 DOI: 10.1002/Jia2.25426 |
0.757 |
|
| 2020 |
Balán IC, Lentz C, Giguere R, Mayo AJ, Rael CT, Soto-Torres L, Palanee-Phillips T, Mgodi NM, Hillier S, Baeten JM. Implementation of a fidelity monitoring process to assess delivery of an evidence-based adherence counseling intervention in a multi-site biomedical HIV prevention study. Aids Care. 1-10. PMID 31899954 DOI: 10.1080/09540121.2019.1709614 |
0.504 |
|
| 2019 |
Stewart J, Bukusi E, Celum C, Delany-Moretlwe S, Baeten JM. Sexually transmitted infections among African women: an underrecognized epidemic and an opportunity for combination STI/HIV prevention. Aids (London, England). PMID 31895144 DOI: 10.1097/QAD.0000000000002472 |
0.55 |
|
| 2019 |
Mera R, Scheer S, Carter C, Das M, Asubonteng J, McCallister S, Baeten J. Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States. Journal of the International Aids Society. 22: e25433. PMID 31860171 DOI: 10.1002/Jia2.25433 |
0.656 |
|
| 2019 |
Kinuthia J, Pintye J, Abuna F, Mugwanya KK, Lagat H, Onyango D, Begnel E, Dettinger J, Baeten JM, John-Stewart G. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. The Lancet. Hiv. PMID 31813837 DOI: 10.1016/S2352-3018(19)30335-2 |
0.584 |
|
| 2019 |
Peebles K, van der Straten A, Palanee-Phillips T, Reddy K, Hillier SL, Hendrix CW, Harkoo I, Mirembe BG, Jeenarain N, Baeten JM, Brown ER. Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31809308 DOI: 10.1097/Qai.0000000000002253 |
0.693 |
|
| 2019 |
Eller MA, Hong T, Creegan M, Nau ME, Sanders-Buell E, Slike B, Krebs SJ, Ratto-Kim S, Mcelrath MJ, Katabira ET, Bolton DL, Michael NL, Robb ML, Tovanabutra S, Baeten JM, et al. Activated PD-1+ CD4 T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART. Aids (London, England). PMID 31764072 DOI: 10.1097/Qad.0000000000002432 |
0.33 |
|
| 2019 |
Bochner AF, Secor WE, Baeten JM, van Dam GJ, Szpiro AA, Njenga SM, Corstjens PLAM, Mackelprang RD, Mugo NR, Overbaugh J, Celum C, Mujugira A, McClelland RS, Barnabas RV. Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies. Plos Neglected Tropical Diseases. 13: e0007886. PMID 31747411 DOI: 10.1371/Journal.Pntd.0007886 |
0.67 |
|
| 2019 |
Ortblad KF, Stalter RM, Bukusi EA, Ngure K, Mujugura A, Celum C, Baeten JM, Heffron R. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda. Aids and Behavior. PMID 31696370 DOI: 10.1007/S10461-019-02720-4 |
0.757 |
|
| 2019 |
Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial. Aids and Behavior. PMID 31667678 DOI: 10.1007/S10461-019-02707-1 |
0.48 |
|
| 2019 |
Nickolas TL, Yin MT, Hong T, Mugwanya KK, Branch AD, Heffron R, Ramalho J, Nandakumar R, Dworakowski E, Wanga V, Mugo NR, Ronald A, Celum C, Donnell D, Baeten JM, et al. Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults. Open Forum Infectious Diseases. 6: ofz338. PMID 31660332 DOI: 10.1093/Ofid/Ofz338 |
0.714 |
|
| 2019 |
Palanee-Phillips T, Baeten JM. Topical delivery of long-acting antiretrovirals to prevent HIV acquisition. Current Opinion in Hiv and Aids. PMID 31658117 DOI: 10.1097/Coh.0000000000000598 |
0.689 |
|
| 2019 |
Gandhi M, Wang G, King R, Rodrigues WC, Vincent M, Glidden DV, Cressey TR, Bacchetti P, Spinellii MA, Okochi H, Siriprakaisil O, Klinbuayaem V, Mugo NR, Ngure K, Drain PK, ... Baeten JM, et al. Development and Validation of the First Point-of-Care Assay to Objectively Monitor Adherence to HIV Treatment and Prevention in Real-Time in Routine Settings. Aids (London, England). PMID 31634188 DOI: 10.1097/QAD.0000000000002395 |
0.365 |
|
| 2019 |
Baeten JM, Hendrix CW, Hillier SL. Topical Microbicides in HIV Prevention: State of the Promise. Annual Review of Medicine. PMID 31613684 DOI: 10.1146/Annurev-Med-090518-093731 |
0.688 |
|
| 2019 |
Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples. Journal of Acquired Immune Deficiency Syndromes (1999). 82: 265-274. PMID 31609925 DOI: 10.1097/Qai.0000000000002139 |
0.799 |
|
| 2019 |
Naluyima P, Lal KG, Costanzo MC, Kijak GH, Gonzalez VD, Blom K, Eller LA, Creegan M, Hong T, Kim D, Quinn TC, Björkström NK, Ljunggren HG, Serwadda D, Katabira ET, ... ... Baeten JM, et al. Terminal Effector CD8 T Cells Defined by an IKZF2IL-7R Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity. Journal of Immunology (Baltimore, Md. : 1950). PMID 31519862 DOI: 10.4049/Jimmunol.1900422 |
0.406 |
|
| 2019 |
Dettinger JC, Kinuthia J, Pintye J, Abuna F, Begnel E, Mugwanya K, Sila J, Lagat H, Baeten JM, John-Stewart G. Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya. Journal of the International Aids Society. 22: e25378. PMID 31498563 DOI: 10.1002/Jia2.25378 |
0.608 |
|
| 2019 |
Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, Dettinger JC, John-Stewart G, Baeten JM. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. Plos Medicine. 16: e1002885. PMID 31479452 DOI: 10.1371/Journal.Pmed.1002885 |
0.644 |
|
| 2019 |
Pyra MN, Haberer JE, Hasen N, Reed J, Mugo NR, Baeten JM. Global implementation of PrEP for HIV prevention: setting expectations for impact. Journal of the International Aids Society. 22: e25370. PMID 31456348 DOI: 10.1002/Jia2.25370 |
0.694 |
|
| 2019 |
Montgomery ET, Roberts ST, Nel A, Malherbe M, Torjesen K, Bunge K, Singh D, Baeten JM, Marrazzo J, Chirenje ZM, Kabwigu S, Beigi R, Riddler SA, Gafoor Z, Reddy K, et al. Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence. Aids (London, England). PMID 31408030 DOI: 10.1097/Qad.0000000000002346 |
0.532 |
|
| 2019 |
Baeten JM. PrEP for HIV: grade A for evidence but pending for impact. Nature Reviews. Urology. PMID 31363183 DOI: 10.1038/S41585-019-0219-X |
0.674 |
|
| 2019 |
Matthews LT, Jaggernath M, Kriel Y, Smith PM, O'Neil K, Haberer JE, Hendrix C, Baeten JM, Ware NC, Wirth K, Psaros C, Bangsberg DR, Smit JA. Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa. Bmj Open. 9: e027227. PMID 31350241 DOI: 10.1136/Bmjopen-2018-027227 |
0.713 |
|
| 2019 |
Ortblad KF, Baeten JM, Cherutich P, Wamicwe JN, Wasserheit JN. The arc of HIV epidemics in sub-Saharan Africa: new challenges with concentrating epidemics in the era of 90-90-90. Current Opinion in Hiv and Aids. PMID 31343457 DOI: 10.1097/Coh.0000000000000569 |
0.684 |
|
| 2019 |
Richert-Spuhler LE, Pattacini L, Plews M, Irungu E, Muwonge TR, Katabira E, Mugo N, Meyers AFA, Celum C, Baeten JM, Lingappa JR, Lund JM. Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women. Aids (London, England). PMID 31335802 DOI: 10.1097/Qad.0000000000002323 |
0.616 |
|
| 2019 |
Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. Journal of the International Aids Society. 22: e25298. PMID 31328444 DOI: 10.1002/Jia2.25298 |
0.691 |
|
| 2019 |
Roberts DA, Barnabas RV, Abuna F, Lagat H, Kinuthia J, Pintye J, Bochner AF, Forsythe S, Gomez GB, Baeten JM, John-Stewart G, Levin C. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya. Journal of the International Aids Society. 22: e25296. PMID 31328443 DOI: 10.1002/Jia2.25296 |
0.506 |
|
| 2019 |
Odoyo JB, Morton JF, Ngure K, O'Malley G, Mugwanya KK, Irungu E, Awuor M, Dolla A, Ongolly F, Bukusi EA, Mugo NR, Baeten JM. Integrating PrEP into HIV care clinics could improve partner testing services and reinforce mutual support among couples: provider views from a PrEP implementation project in Kenya. Journal of the International Aids Society. 22: e25303. PMID 31321911 DOI: 10.1002/Jia2.25303 |
0.584 |
|
| 2019 |
Drain PK, Kubiak RW, Siriprakaisil O, Klinbuayaem V, Quame-Amaglo J, Sukrakanchana PO, Tanasri S, Punyati P, Sirirungsi W, Cressey R, Bacchetti P, Okochi H, Baeten JM, Gandhi M, Cressey TR. confUrine Tenofovir Concentrations Correlate with Plasma and Relates to TDF Adherence: A Randomized Directly-observed Pharmacokinetic Trial (TARGET Study). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31314073 DOI: 10.1093/Cid/Ciz645 |
0.309 |
|
| 2019 |
Patel RC, Stalter RM, Thomas KK, Tamraz B, Blue SW, Erikson DW, Kim CJ, Kelley EJ, Nanda K, Kourtis AP, Lingappa JR, Mugo N, Baeten JM, Scarsi KK. A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda. Aids (London, England). PMID 31306173 DOI: 10.1097/Qad.0000000000002308 |
0.497 |
|
| 2019 |
Palanee-Phillips T, Brown ER, Szydlo D, Matovu Kiweewa F, Pather A, Harkoo I, Nair G, Soto-Torres L, Hillier SL, Baeten JM. Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study. Aids (London, England). 33: 1619-1622. PMID 31306167 DOI: 10.1097/Qad.0000000000002260 |
0.682 |
|
| 2019 |
Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, Donnell D, Mugo NR, Baeten JM, Ngure K. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya. Trials. 20: 396. PMID 31272495 DOI: 10.1186/S13063-019-3521-2 |
0.62 |
|
| 2019 |
Velloza J, Delany-Moretlwe S, Baeten JM. Comprehensive HIV risk reduction interventions for 2020 and beyond: product choices and effective service-delivery platforms for individual needs and population-level impact. Current Opinion in Hiv and Aids. PMID 31261158 DOI: 10.1097/Coh.0000000000000567 |
0.553 |
|
| 2019 |
Kimemia G, Ngure K, Baeten JM, Celum C, Dew K, Njuguna N, Mugo N, Heffron R. Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya. Reproductive Health. 16: 85. PMID 31215447 DOI: 10.1186/S12978-019-0751-4 |
0.786 |
|
| 2019 |
Peebles K, Baeten JM. Cost-effectiveness of HIV Prevention Interventions: Estimates from Real-world Implementation Needed. Eclinicalmedicine. 10: 8-9. PMID 31193844 DOI: 10.1016/J.Eclinm.2019.05.002 |
0.533 |
|
| 2019 |
Irungu EM, Sharma M, Maronga C, Mugo N, Ngure K, Celum C, Barnabas RV, Baeten J, Heffron R. The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya. Aids Research and Treatment. 2019: 4170615. PMID 31186955 DOI: 10.1155/2019/4170615 |
0.777 |
|
| 2019 |
Mugwanya KK, Baeten JM. Next-Generation Pre-Exposure Prophylaxis: Choices for Effective HIV Prevention. The Journal of Infectious Diseases. PMID 31175817 DOI: 10.1093/Infdis/Jiz273 |
0.654 |
|
| 2019 |
Pyra M, Anderson P, Haberer JE, Heffron R, Celum C, Asiimwe S, Katabira E, Mugo NR, Bukusi EA, Baeten JM. Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women. Frontiers in Pharmacology. 10: 401. PMID 31057407 DOI: 10.3389/Fphar.2019.00401 |
0.657 |
|
| 2019 |
Sabo MC, Richardson BA, Lavreys L, Martin HL, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J, McClelland RS. Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion. Aids (London, England). 33: 1225-1230. PMID 31048629 DOI: 10.1097/Qad.0000000000002167 |
0.702 |
|
| 2019 |
Sugarman J, Lin L, Baeten JM, Palanee-Phillips T, Brown ER, Matovu Kiweewa F, Mgodi NM, Nair G, Siva S, Seils DM, Weinfurt KP. Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial. Ajob Empirical Bioethics. 1-9. PMID 31002583 DOI: 10.1080/23294515.2019.1593257 |
0.619 |
|
| 2019 |
Velloza J, Ngure K, Kiptinness C, Quame-Amaglo J, Thuo N, Dew K, Kimani M, Gakuo S, Unger JA, Kolko B, Baeten JM, Celum C, Mugo N, Heffron R. A clinic-based tablet application to support safer conception among HIV serodiscordant couples in Kenya: feasibility and acceptability study. Mhealth. 5: 4. PMID 30976596 DOI: 10.21037/mhealth.2019.01.04 |
0.787 |
|
| 2019 |
Heffron R, Ngure K, Velloza J, Kiptinness C, Quame-Amalgo J, Oluch L, Thuo N, Njoroge J, Momanyi R, Gakuo S, Mbugua S, Morrison S, Haugen H, Chohan B, Celum C, ... Baeten JM, et al. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness. Journal of the International Aids Society. 22: e25261. PMID 30957420 DOI: 10.1002/Jia2.25261 |
0.798 |
|
| 2019 |
Pintye J, Drake AL, Begnel E, Kinuthia J, Abuna F, Lagat H, Dettinger J, Wagner AD, Thirumurthy H, Mugwanya K, Baeten JM, John-Stewart G. Acceptability and outcomes of distributing HIV self-tests for male partner testing in Kenyan maternal child health and family planning clinics. Aids (London, England). PMID 30932954 DOI: 10.1097/Qad.0000000000002211 |
0.602 |
|
| 2019 |
Irungu EM, Ngure K, Mugwanya K, Mugo N, Bukusi E, Wamoni E, Odoyo J, Morton JF, Bernabee G, Mambo B, Masyuko S, Mukui I, O'Malley G, Baeten JM. Training health care providers to provide PrEP for HIV serodiscordant couples attending public health facilities in Kenya. Global Public Health. 1-11. PMID 30871413 DOI: 10.1080/17441692.2019.1588908 |
0.557 |
|
| 2019 |
Dettinger JC, Kinuthia J, Pintye J, Mwongeli N, Gómez L, Richardson BA, Barnabas R, Wagner AD, O'Malley G, Baeten JM, John-Stewart G. PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial. Bmj Open. 9: e025122. PMID 30850409 DOI: 10.1136/Bmjopen-2018-025122 |
0.71 |
|
| 2019 |
Kiweewa FM, Brown E, Mishra A, Nair G, Palanee-Phillips T, Mgodi N, Nakabiito C, Chakhtoura N, Hillier SL, Baeten JM. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women. Journal of the International Aids Society. 22: e25257. PMID 30816632 DOI: 10.1002/Jia2.25257 |
0.539 |
|
| 2019 |
Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG. PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa. Journal of the International Association of Providers of Aids Care. 18: 2325958219831011. PMID 30776954 DOI: 10.1177/2325958219831011 |
0.602 |
|
| 2019 |
Mackelprang RD, Bamshad MJ, Chong JX, Hou X, Buckingham KJ, Shively K, deBruyn G, Mugo NR, Mullins JI, McElrath MJ, Baeten JM, Celum C, Emond MJ, Lingappa JR. Correction: Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1. Plos Pathogens. 15: e1007588. PMID 30742678 DOI: 10.1371/journal.ppat.1007588 |
0.358 |
|
| 2019 |
McMahan VM, Martin A, Garske L, Violette LR, Andrasik MP, Baeten JM, Banta-Green C, Stekler JD. Development of a targeted educational intervention to increase pre-exposure prophylaxis uptake among cisgender men and transgender individuals who have sex with men and use methamphetamine in Seattle (WA, USA). Sexual Health. PMID 30739638 DOI: 10.1071/Sh18060 |
0.43 |
|
| 2019 |
Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, Baeten JM, Katabira ET, Ware NC. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples. Journal of the International Aids Society. 22: e25225. PMID 30657642 DOI: 10.1002/Jia2.25225 |
0.706 |
|
| 2019 |
Gill K, Celum C, Breen G, Thomas K, Morton J, Baeten J, Mendel E, Duyver M, Bekker L. P432 High prevalence and incidence of curable STIs among young women initiating PrEP in a township in south africa Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.518 |
0.484 |
|
| 2019 |
Stewart J, Omollo V, Odoyo J, Kidoguchi L, Morton J, Johnson R, Celum C, Baeten J, Bukusi E. P424 High prevalence and incidence of bacterial STIs in young women at high risk of HIV prior to PrEP scale-up in kenya Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.510 |
0.628 |
|
| 2019 |
Delany-Moretlwe S, Mgodi N, Bekker L, Baeten J, Pathak S, Donnell D, Lennon D, Rose S, Makgamathe K, Kassim S, Mukaka S, Noble H, Adeyeye A, Celum C. O10.3 High curable STI prevalence and incidence among young african women initiating PrEP in HPTN 082 Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.160 |
0.479 |
|
| 2018 |
Heffron R, Stalter R, Pyra M, Nanda K, Erikson DW, Hladik F, Blue SW, Davis NL, Mugo N, Kourtis AP, Lingappa JR, Baeten JM. HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study. Aids (London, England). PMID 30585845 DOI: 10.1097/Qad.0000000000002123 |
0.758 |
|
| 2018 |
Beima-Sofie KM, Trinidad SB, Ngure K, Heffron R, Baeten JM, John-Stewart GC, Kelley M. Lessons from PrEP: A Qualitative Study Investigating How Clinical and Policy Experts Weigh Ethics and Evidence When Evaluating Preventive Medications for Use in Pregnant and Breastfeeding Women. Aids and Behavior. PMID 30552519 DOI: 10.1007/S10461-018-2361-5 |
0.667 |
|
| 2018 |
Zablotska IB, Baeten JM, Phanuphak N, McCormack S, Ong J. Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and examples of successful health service models of PrEP implementation. Sexual Health. 15: 481-484. PMID 30496716 DOI: 10.1071/Sh18182 |
0.33 |
|
| 2018 |
Pintye J, Singa B, Wanyonyi K, Itindi J, Kinuthia J, Langat A, Nganga L, Katana A, Baeten JM, McGrath CJ, John-Stewart G. Preexposure Prophylaxis for Human Immunodeficiency Virus (HIV) Prevention Among HIV-uninfected Pregnant Women: Estimated Coverage Using Risk-based Versus Regional Prevalence Approaches. Sexually Transmitted Diseases. 45: e98-e100. PMID 30422971 DOI: 10.1097/Olq.0000000000000898 |
0.647 |
|
| 2018 |
Masyuko S, Mukui I, Njathi O, Kimani M, Oluoch P, Wamicwe J, Mutegi J, Njogo S, Anyona M, Muchiri P, Maikweki L, Musyoki H, Bahati P, Kyongo J, Marwa T, ... ... Baeten JM, et al. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study. Sexual Health. PMID 30408432 DOI: 10.1071/Sh18090 |
0.625 |
|
| 2018 |
Muwonge TR, Ngure K, Katabira E, Mugo N, Kimemia G, Burns BFO, Musinguzi N, Bambia F, Baeten JM, Heffron R, Haberer JE. Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study. Aids and Behavior. PMID 30406335 DOI: 10.1007/S10461-018-2326-8 |
0.748 |
|
| 2018 |
Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y, Moodley J, Kintu K, Reddy K, Kabwigu S, Jeenariain N, Harkoo I, Mgodi N, Piper J, Rees H, ... ... Baeten JM, et al. Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30383589 DOI: 10.1097/Qai.0000000000001861 |
0.492 |
|
| 2018 |
Riddler SA, Balkus JE, Parikh UM, Mellors JW, Akello C, Dadabhai S, Mhlanga F, Ramjee G, Mayo AJ, Livant E, Heaps AL, O'Rourke C, Baeten JM. Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30346511 DOI: 10.1093/Cid/Ciy909 |
0.683 |
|
| 2018 |
Dombrowski JC, Baeten JM. It's Time to Make the Time to Viral Suppression After HIV Diagnosis a Metric of HIV Care Success. The Journal of Infectious Diseases. PMID 30304499 DOI: 10.1093/Infdis/Jiy539 |
0.641 |
|
| 2018 |
Mugo NR, Eckert L, Magaret AS, Cheng A, Mwaniki L, Ngure K, Celum C, Baeten JM, Galloway DA, Wamalwa D, Wald A. Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status. Vaccine. PMID 30297124 DOI: 10.1016/J.Vaccine.2018.09.059 |
0.466 |
|
| 2018 |
Stekler JD, Violette LR, Niemann L, McMahan VM, Katz DA, Baeten JM, Grant RM, Delaney KP. Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis. Open Forum Infectious Diseases. 5: ofy197. PMID 30276221 DOI: 10.1093/Ofid/Ofy197 |
0.663 |
|
| 2018 |
Palanee-Phillips T, Roberts ST, Reddy K, Vaneshree Govender, Naidoo L, Siva S, Gafoor Z, Pather A, Matovu F, Hlahla K, Makanani B, Nair G, Schwartz K, Torjesen K, Brown E, ... ... Baeten J, et al. Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a phase III trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30239426 DOI: 10.1097/Qai.0000000000001866 |
0.564 |
|
| 2018 |
Pintye J, Kinuthia J, Roberts DA, Wagner AD, Mugwanya K, Abuna F, Lagat H, Owiti G, Levin C, Barnabas RV, Baeten JM, John-Stewart G. Integration of PrEP Services Into Routine Antenatal and Postnatal care: Experiences from an Implementation Program in Western Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30204720 DOI: 10.1097/Qai.0000000000001850 |
0.469 |
|
| 2018 |
Mugwanya KK, Irungu E, Bukusi E, Mugo NR, Odoyo J, Wamoni E, Ngure K, Morton JF, Peebles K, Masyuko S, Barnabee G, Donnell D, Barnabas R, Haberer J, O'Malley G, ... Baeten JM, et al. Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya. Implementation Science : Is. 13: 118. PMID 30180860 DOI: 10.1186/S13012-018-0809-7 |
0.658 |
|
| 2018 |
Velloza J, Baeten JM, Haberer J, Ngure K, Irungu E, Mugo N, Celum C, Heffron R. The Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30063651 DOI: 10.1097/Qai.0000000000001821 |
0.575 |
|
| 2018 |
Pintye J, Singa B, Wanyonyi K, Itindi J, Kinuthia J, Langat A, Nganga L, Katana A, Baeten J, McGrath CJ, John-Stewart GC. Pre-exposure prophylaxis (PrEP) for HIV prevention among HIV-uninfected pregnant women: estimated coverage using risk-based versus regional prevalence approaches. Sexually Transmitted Diseases. PMID 30044335 DOI: 10.1097/OLQ.0000000000000898 |
0.599 |
|
| 2018 |
Pintye J, Beima-Sofie KM, Makabong'O PA, Njoroge A, Trinidad SB, Heffron RA, Baeten JM, Celum C, Matemo D, Kinuthia J, Kelley MC, John-Stewart GC. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Preexposure Prophylaxis During Pregnancy. Aids Patient Care and Stds. PMID 30036072 DOI: 10.1089/Apc.2018.0058 |
0.796 |
|
| 2018 |
Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM. Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. Aids and Behavior. PMID 30006791 DOI: 10.1007/S10461-018-2221-3 |
0.768 |
|
| 2018 |
Musinguzi N, Muwonge T, Ngure K, Katabira E, Mugo N, Burns BFO, Baeten JM, Heffron R, Haberer JE. Comparison of SMS self-reported adherence with other adherence measures in a demonstration project of HIV pre-exposure prophylaxis in Kenya and Uganda. Aids (London, England). PMID 30005025 DOI: 10.1097/Qad.0000000000001955 |
0.649 |
|
| 2018 |
Heffron R, Mugo N, Hong T, Celum C, Marzinke MA, Ngure K, Asiimwe S, Katabira E, Bukusi EA, Odoyo J, Tindimwebwa E, Bulya N, Baeten JM. Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention. Aids (London, England). 32: 1707-1713. PMID 30001244 DOI: 10.1097/Qad.0000000000001867 |
0.757 |
|
| 2018 |
Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM, et al. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral pre-exposure prophylaxis. Aids (London, England). PMID 29894385 DOI: 10.1097/Qad.0000000000001922 |
0.756 |
|
| 2018 |
Ware NC, Pisarski EE, Nakku-Joloba E, Wyatt MA, Muwonge TR, Turyameeba B, Asiimwe SB, Heffron RA, Baeten JM, Celum CL, Katabira ET. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda. Journal of the International Aids Society. 21: e25113. PMID 29851436 DOI: 10.1002/Jia2.25113 |
0.738 |
|
| 2018 |
Golovaty I, Sharma M, Van Heerden A, van Rooyen H, Baeten JM, Celum C, Barnabas RV. Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29771779 DOI: 10.1097/Qai.0000000000001713 |
0.497 |
|
| 2018 |
Heffron R, Mugo N, Hong T, Celum C, Marzinke MA, Ngure K, Asiimwe S, Katabira E, Bukusi E, Odoyo J, Tindimwebwa E, Bulya N, Baeten JM. Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention. Aids (London, England). PMID 29762175 DOI: 10.1097/QAD.0000000000001867 |
0.721 |
|
| 2018 |
Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, Ngure K, Kiarie J, Mugo N, Heffron R. Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners. The Journal of Infectious Diseases. PMID 29514254 DOI: 10.1093/Infdis/Jiy113 |
0.815 |
|
| 2018 |
Baeten JM. Amplifying the Population Health Benefits of PrEP for HIV Prevention. The Journal of Infectious Diseases. PMID 29506050 DOI: 10.1093/Infdis/Jiy045 |
0.599 |
|
| 2018 |
Hancuch K, Baeten J, Ngure K, Celum C, Mugo N, Tindimwebwa E, Heffron R. Safer conception among HIV-1 serodiscordant couples in East Africa: understanding knowledge, attitudes, and experiences. Aids Care. 1-9. PMID 29455572 DOI: 10.1080/09540121.2018.1437251 |
0.782 |
|
| 2018 |
Pyra M, Lingappa JR, Heffron R, Erikson DW, Blue SW, Patel RC, Nanda K, Rees H, Mugo NR, Davis NL, Kourtis AP, Baeten JM. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women. Contraception. PMID 29408422 DOI: 10.1016/J.Contraception.2018.01.011 |
0.718 |
|
| 2018 |
Blue SW, Winchell AJ, Kaucher AV, Lieberman RA, Gilles CT, Pyra MN, Heffron R, Hou X, Coombs RW, Nanda K, Davis NL, Kourtis AP, Herbeck JT, Baeten JM, Lingappa JR, et al. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS. Contraception. PMID 29407362 DOI: 10.1016/J.Contraception.2018.01.015 |
0.485 |
|
| 2018 |
McClelland RS, Lingappa JR, Srinivasan S, Kinuthia J, John-Stewart GC, Jaoko W, Richardson BA, Yuhas K, Fiedler TL, Mandaliya KN, Munch MM, Mugo NR, Cohen CR, Baeten JM, Celum C, et al. Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study. The Lancet. Infectious Diseases. PMID 29396006 DOI: 10.1016/S1473-3099(18)30058-6 |
0.681 |
|
| 2018 |
Shapiro AE, van Heerden A, Schaafsma TT, Hughes JP, Baeten JM, van Rooyen H, Tumwesigye E, Celum CL, Barnabas RV. Completion of the tuberculosis care cascade in a community-based HIV linkage-to-care study in South Africa and Uganda. Journal of the International Aids Society. 21. PMID 29381257 DOI: 10.1002/Jia2.25065 |
0.525 |
|
| 2017 |
Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, Kidoguchi L, Donnell D, Mugo NR, Bukusi EA, Katabira E, Asiimwe S, Morton J, Morrison S, Haugen H, ... ... Baeten JM, et al. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Research. 1: 3. PMID 29355231 DOI: 10.12688/gatesopenres.12752.1 |
0.803 |
|
| 2017 |
Hofmeyr GJ, Morrison CS, Baeten JM, Chipato T, Donnell D, Gichangi P, Mugo N, Nanda K, Rees H, Steyn P, Taylor D. Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). Gates Open Research. 1: 17. PMID 29355224 DOI: 10.12688/gatesopenres.12775.1 |
0.627 |
|
| 2017 |
Ngure K, Trinidad SB, Beima-Sofie K, Baeten JM, Mugo NR, Bukusi EA, Heffron R, John-Stewart G, Kelley MC. The role of male partners in women's participation in research during pregnancy: a case study from the partners demonstration project. Reproductive Health. 14: 160. PMID 29297375 DOI: 10.1186/S12978-017-0424-0 |
0.634 |
|
| 2017 |
King CC, Ellington SR, Davis NL, Coombs RW, Pyra M, Hong T, Mugo N, Patel RC, Lingappa JR, Baeten JM, Kourtis AP. Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy. The Journal of Infectious Diseases. PMID 29240922 DOI: 10.1093/Infdis/Jix550 |
0.692 |
|
| 2017 |
Ross JM, Ying R, Celum CL, Baeten JM, Thomas KK, Murnane PM, van Rooyen H, Hughes JP, Barnabas RV. Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs. Epidemics. PMID 29223580 DOI: 10.1016/J.Epidem.2017.12.001 |
0.669 |
|
| 2017 |
Laborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M, Naidoo S, Palanee-Phillips T, Baeten JM, Montgomery ET. Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex. Aids and Behavior. PMID 29151197 DOI: 10.1007/S10461-017-1977-1 |
0.498 |
|
| 2017 |
Mugwanya KK, Baeten JM, Wyatt C, Mugo NR, Celum CL, Ronald A, Kiarie J, Katabira E, Heffron R. Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29135656 DOI: 10.1097/Qai.0000000000001575 |
0.701 |
|
| 2017 |
Mackelprang RD, Bamshad MJ, Chong JX, Hou X, Buckingham KJ, Shively K, deBruyn G, Mugo NR, Mullins JI, McElrath MJ, Baeten JM, Celum C, Emond MJ, Lingappa JR. Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1. Plos Pathogens. 13: e1006703. PMID 29108000 DOI: 10.1371/Journal.Ppat.1006703 |
0.657 |
|
| 2017 |
Cabral A, Baeten J, Ngure K, Velloza J, Odoyo J, Haberer J, Celum C, Muwonge T, Asiimwe S, Heffron R. Intimate partner violence and self-reported pre-exposure prophylaxis (PrEP) interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29076883 DOI: 10.1097/Qai.0000000000001574 |
0.803 |
|
| 2017 |
Pintye J, Baeten JM, Celum C, Mugo N, Ngure K, Were E, Bukusi E, John-Stewart G, Heffron RA. Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study. The Journal of Infectious Diseases. PMID 29040666 DOI: 10.1093/Infdis/Jix542 |
0.694 |
|
| 2017 |
Pyra M, Haberer JE, Heffron R, Kidoguchi L, Brown ER, Bukusi EA, Asiimwe S, Celum C, Katabira E, Mugo NR, Baeten JM. PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29016523 DOI: 10.1097/Qai.0000000000001561 |
0.788 |
|
| 2017 |
Balkus JE, Brown ER, Palanee-Phillips T, Kiweewa FM, Mgodi N, Naidoo L, Mbilizi Y, Jeenarain N, Gaffoor Z, Siva S, Nair G, Pather A, Baeten JM. Performance of a validated risk score to predict HIV-1 acquisition among African women participating in a trial of the dapivirine vaginal ring. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28961677 DOI: 10.1097/Qai.0000000000001556 |
0.571 |
|
| 2017 |
Haberer JE, Ngure K, Muwonge T, Mugo N, Katabira E, Heffron R, Musinguzi N, Bangsberg DR, Celum C, Baeten JM. Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28961676 DOI: 10.1097/Qai.0000000000001548 |
0.777 |
|
| 2017 |
Patel RC, Leddy AM, Odoyo J, Anand K, Stanford-Moore G, Wakhungu I, Bukusi EA, Baeten JM, Brown JM. What motivates serodiscordant couples to prevent HIV transmission within their relationships: findings from a PrEP implementation study in Kenya. Culture, Health & Sexuality. 1-15. PMID 28903628 DOI: 10.1080/13691058.2017.1367421 |
0.673 |
|
| 2017 |
Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odoyo J, Tindimwebwa E, Bulya N, Katabira E, Heffron R. High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy. Aids Research and Human Retroviruses. PMID 28899162 DOI: 10.1089/AID.2017.0020 |
0.707 |
|
| 2017 |
Heffron R, Thomson K, Celum C, Haberer J, Ngure K, Mugo N, Bukusi E, Katabira E, Odoyo J, Bulya N, Asiimwe S, Tindimwebwa E, Baeten JM. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples. Aids and Behavior. PMID 28894986 DOI: 10.1007/S10461-017-1902-7 |
0.809 |
|
| 2017 |
Patel RC, Bukusi EA, Baeten JM. Current and future contraceptive options for women living with HIV. Expert Opinion On Pharmacotherapy. PMID 28891343 DOI: 10.1080/14656566.2017.1378345 |
0.618 |
|
| 2017 |
Pintye J, Beima-Sofie KM, Kimemia G, Ngure K, Trinidad SB, Heffron R, Baeten J, Odoyo J, Mugo N, Bukusi EA, Kelley MC, John-Stewart GC. "I did not want to give birth to a child who has HIV": Experiences using PrEP during pregnancy among HIV-uninfected Kenyan women in HIV-serodiscordant couples. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28777265 DOI: 10.1097/Qai.0000000000001516 |
0.801 |
|
| 2017 |
Husnik MJ, Brown ER, Marzinke M, Livant E, Palanee-Phillips T, Hendrix C, Kiweewa FM, Nair G, Soto-Torres LE, Schwartz K, Hillier SL, Baeten JM. Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28746164 DOI: 10.1097/Qai.0000000000001503 |
0.631 |
|
| 2017 |
Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. Journal of the International Aids Society. 20: 1-9. PMID 28741331 DOI: 10.7448/Ias.20.1.21842 |
0.785 |
|
| 2017 |
Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, Bukusi E, Donnell D, Lingappa J, Kiarie J, Fiedler T, Munch M, Fredricks DN, Baeten JM. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. The Lancet. Hiv. PMID 28732773 DOI: 10.1016/S2352-3018(17)30110-8 |
0.738 |
|
| 2017 |
Cressey TR, Siriprakaisil O, Klinbuayaem V, Quame-Amaglo J, Kubiak RW, Sukrakanchana PO, Than-In-At K, Baeten J, Sirirungsi W, Cressey R, Drain PK. A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study. Bmc Infectious Diseases. 17: 496. PMID 28705153 DOI: 10.1186/S12879-017-2593-4 |
0.402 |
|
| 2017 |
Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, Lingappa JR, Ronald A, Fife K, Coombs RW. The Effect of Oral Pre-Exposure Prophylaxis on the Progression of HIV-1 Seroconversion. Aids (London, England). PMID 28692542 DOI: 10.1097/Qad.0000000000001577 |
0.641 |
|
| 2017 |
Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda. Aids and Behavior. PMID 28634661 DOI: 10.1007/S10461-017-1829-Z |
0.669 |
|
| 2017 |
Mugwanya KK, John-Stewart G, Baeten J. Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women. Expert Opinion On Drug Safety. 1-5. PMID 28571500 DOI: 10.1080/14740338.2017.1338271 |
0.707 |
|
| 2017 |
Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K, Nair G, Chappell C, Kiweewa FM, Kabwigu S, Naidoo L, Jeenarain N, Marzinke M, Soto-Torres L, ... ... Baeten JM, et al. Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28542081 DOI: 10.1097/Qai.0000000000001455 |
0.455 |
|
| 2017 |
Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, et al. Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. The Journal of Infectious Diseases. 215: 907-910. PMID 28453835 DOI: 10.1093/Infdis/Jix029 |
0.461 |
|
| 2017 |
Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, ... Baeten JM, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. Aids (London, England). 31: 1159-1167. PMID 28441175 DOI: 10.1097/Qad.0000000000001452 |
0.493 |
|
| 2017 |
Patel RC, Baeten JM, Heffron R, Hong T, Davis NL, Nanda K, Coombs RW, Lingappa JR, Bukusi EA, Hurst S, Thomas KK, Kourtis AP, Mugo N. Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data. Journal of Acquired Immune Deficiency Syndromes (1999). 75: 91-96. PMID 28399558 DOI: 10.1097/QAI.0000000000001339 |
0.744 |
|
| 2017 |
Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV. A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples. Sexually Transmitted Infections. PMID 28377421 DOI: 10.1136/Sextrans-2016-053034 |
0.544 |
|
| 2017 |
Ngure K, Heffron R, Mugo N, Thomson KA, Irungu E, Njuguna N, Mwaniki L, Celum C, Baeten JM. Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya. Journal of the International Aids Society. 20: 1-8. PMID 28362073 DOI: 10.7448/Ias.20.1.21234 |
0.8 |
|
| 2017 |
Ngure K, Kimemia G, Dew K, Njuguna N, Mugo N, Celum C, Baeten JM, Heffron R. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples. Journal of the International Aids Society. 20: 52-58. PMID 28361508 DOI: 10.7448/Ias.20.2.21309 |
0.804 |
|
| 2017 |
Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, et al. HSV-2 acquisition among HIV-1 infected adults treated with tenofovir as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study. The Journal of Infectious Diseases. PMID 28329270 DOI: 10.1093/infdis/jix029 |
0.423 |
|
| 2017 |
Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, ... Baeten JM, et al. "It's inside my body and it's mine". Aids (London, England). PMID 28323754 DOI: 10.1097/QAD.0000000000001452 |
0.413 |
|
| 2017 |
Thomson KA, Haberer JE, Marzinke M, Mujugira A, Hendrix C, Celum C, Ndase P, Ronald A, Bangsberg DR, Baeten JM. Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28291050 DOI: 10.1097/Qai.0000000000001356 |
0.705 |
|
| 2017 |
Buttolph J, Inwani I, Agot K, Cleland CM, Cherutich P, Kiarie JN, Osoti A, Celum CL, Baeten JM, Nduati R, Kinuthia J, Hallett TB, Alsallaq R, Kurth AE. Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol. Jmir Research Protocols. 6: e22. PMID 28274904 DOI: 10.2196/Resprot.5833 |
0.691 |
|
| 2017 |
Baeten JM, Brown ER, Hillier SL. Dapivirine Vaginal Ring for HIV-1 Prevention. The New England Journal of Medicine. 376: 995-6. PMID 28273023 DOI: 10.1056/Nejmc1616546 |
0.669 |
|
| 2017 |
Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR. Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis. Journal of Virology. 91. PMID 28100808 DOI: 10.1128/Jvi.02074-16 |
0.591 |
|
| 2017 |
Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R, et al. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 74: S15-S22. PMID 27930607 DOI: 10.1097/Qai.0000000000001210 |
0.81 |
|
| 2017 |
Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R, et al. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 74: S15-S22. PMID 27923009 DOI: 10.1097/QAI.0000000000001210 |
0.789 |
|
| 2017 |
Pyra M, Lingappa J, Erikson D, Blue S, Heffron R, Mugo N, Nanda K, Davis N, Kourtis A, Baeten J. Validity of self-reported hormonal contraceptive use among women with and at risk for HIV American Journal of Obstetrics and Gynecology. 217: 737. DOI: 10.1016/J.Ajog.2017.08.030 |
0.746 |
|
| 2016 |
Smith JA, Heffron R, Butler AR, Celum C, Baeten JM, Hallett TB. Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk? Contraception. PMID 28038949 DOI: 10.1016/J.Contraception.2016.12.003 |
0.728 |
|
| 2016 |
Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, Bukusi EA, Baeten JM, Brown JM. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya. Journal of the International Aids Society. 19: 21134. PMID 27964776 DOI: 10.7448/Ias.19.1.21134 |
0.689 |
|
| 2016 |
Patel RC, Odoyo J, Anand K, Stanford-Moore G, Wakhungu I, Bukusi EA, Baeten JM, Brown JM. Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study. Plos One. 11: e0168057. PMID 27930740 DOI: 10.1371/Journal.Pone.0168057 |
0.607 |
|
| 2016 |
Madrasi K, Chaturvedula A, Haberer JE, Sale M, Fossler MJ, Bangsberg D, Baeten JM, Celum C, Hendrix CW. Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis. Journal of Clinical Pharmacology. PMID 27922719 DOI: 10.1002/Jcph.843 |
0.475 |
|
| 2016 |
Mujugira A, Celum C, Ngure K, Thomas KK, Katabira E, Baeten JM. Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships. Sexually Transmitted Diseases. PMID 27898566 DOI: 10.1097/Olq.0000000000000534 |
0.573 |
|
| 2016 |
Andersen-Nissen E, Chang JT, Thomas KK, Adams D, Celum C, Sanchez J, Coombs RW, McElrath MJ, Baeten JM. Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines. Sexually Transmitted Diseases. 43: 761-764. PMID 27832025 DOI: 10.1097/Olq.0000000000000523 |
0.585 |
|
| 2016 |
Kourtis AP, Wiener J, King CC, Heffron R, Mugo NR, Nanda K, Pyra M, Donnell D, Celum C, Lingappa JR, Baeten JM. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-infected African women. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27787340 DOI: 10.1097/Qai.0000000000001199 |
0.687 |
|
| 2016 |
Irungu EM, Heffron R, Mugo N, Ngure K, Katabira E, Bulya N, Bukusi E, Odoyo J, Asiimwe S, Tindimwebwa E, Celum C, Baeten JM. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention. Bmc Infectious Diseases. 16: 571. PMID 27751179 DOI: 10.1186/S12879-016-1899-Y |
0.808 |
|
| 2016 |
Heffron R, Parikh UM, Penrose KJ, Mugo N, Donnell D, Celum C, Mellors JW, Baeten JM. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception. Aids and Behavior. PMID 27699594 DOI: 10.1007/S10461-016-1563-Y |
0.719 |
|
| 2016 |
Mugwanya KK, Hendrix CW, Mugo NR, Marzinke M, Katabira ET, Ngure K, Semiyaga NB, John-Stewart G, Muwonge TR, Muthuri G, Stergachis A, Celum CL, Baeten JM. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption. Plos Medicine. 13: e1002132. PMID 27676257 DOI: 10.1371/Journal.Pmed.1002132 |
0.416 |
|
| 2016 |
Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR. HIV-1-neutralizing IgA is detected in genital secretions of highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis. Journal of Virology. PMID 27558421 DOI: 10.1128/Jvi.01482-16 |
0.714 |
|
| 2016 |
Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Hendrix C, Marzinke MA, et al. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. Plos Medicine. 13: e1002099. PMID 27552090 DOI: 10.1371/Journal.Pmed.1002099 |
0.806 |
|
| 2016 |
Carroll JJ, Heffron R, Mugo N, Ngure K, Ndase P, Asiimwe S, Celum C, Baeten JM. Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis. Sexually Transmitted Diseases. 43: 471-475. PMID 27419812 DOI: 10.1097/Olq.0000000000000472 |
0.719 |
|
| 2016 |
Baeten JM. Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection. The Journal of Infectious Diseases. PMID 27418049 DOI: 10.1093/Infdis/Jiw224 |
0.65 |
|
| 2016 |
Lu Y, Goti V, Chaturvedula A, Haberer JE, Fossler MJ, Sale ME, Bangsberg D, Baeten JM, Celum CL, Hendrix CW. Population pharmacokinetics of tenofovir in HIV-1 uninfected members of sero-discordant couples and effect of dose reporting methods. Antimicrobial Agents and Chemotherapy. PMID 27353269 DOI: 10.1128/Aac.00559-16 |
0.461 |
|
| 2016 |
Ngure K, Vusha S, Mugo N, Emmanuel-Fabula M, Ngutu M, Celum C, Baeten JM, Heffron R. "I never thought that it would happen … " Experiences of HIV seroconverters among HIV-discordant partnerships in a prospective HIV prevention study in Kenya. Aids Care. 1-4. PMID 27264119 DOI: 10.1080/09540121.2016.1191610 |
0.811 |
|
| 2016 |
Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, Tappero JW, Kiarie J, Ronald A, Mujugira A, Tumwesigye E, Were E, Irungu E, Baeten JM. Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: A prospective cohort study. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27243900 DOI: 10.1097/Qai.0000000000001093 |
0.685 |
|
| 2016 |
Ying R, Sharma M, Celum C, Baeten JM, van Rooyen H, Hughes JP, Garnett G, Barnabas RV. Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis. The Lancet. Hiv. 3: e275-82. PMID 27240790 DOI: 10.1016/S2352-3018(16)30009-1 |
0.676 |
|
| 2016 |
Njuguna N, Ngure K, Mugo N, Sambu C, Sianyo C, Gakuo S, Irungu E, Baeten J, Heffron R. The Effect of Human Immunodeficiency Virus Prevention and Reproductive Health Text Messages on Human Immunodeficiency Virus Testing Among Young Women in Rural Kenya: A Pilot Study. Sexually Transmitted Diseases. 43: 353-359. PMID 27200519 DOI: 10.1097/Olq.0000000000000450 |
0.757 |
|
| 2016 |
Roberts ST, Khanna AS, Barnabas RV, Goodreau SM, Baeten JM, Celum C, Cassels S. Estimating the impact of universal antiretroviral therapy for HIV serodiscordant couples through home HIV testing: insights from mathematical models. Journal of the International Aids Society. 19: 20864. PMID 27174911 DOI: 10.7448/Ias.19.1.20864 |
0.689 |
|
| 2016 |
Barnabas RV, van Rooyen H, Tumwesigye E, Brantley J, Baeten JM, van Heerden A, Turyamureeba B, Joseph P, Krows M, Thomas KK, Schaafsma TT, Hughes JP, Celum C. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. The Lancet. Hiv. 3: e212-20. PMID 27126488 DOI: 10.1016/S2352-3018(16)00020-5 |
0.649 |
|
| 2016 |
Mujugira A, Celum C, Coombs RW, Campbell JD, Ndase P, Ronald A, Were E, Bukusi EA, Mugo N, Kiarie J, Baeten JM. HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27070123 DOI: 10.1097/Qai.0000000000001019 |
0.613 |
|
| 2016 |
Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, Baeten JM. Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy. The Journal of Infectious Diseases. PMID 27053765 DOI: 10.1093/Infdis/Jiw131 |
0.772 |
|
| 2016 |
Mugwanya K, Baeten J, Celum C, Donnell D, Nickolas T, Mugo N, Branch A, Tappero J, Kiarie J, Ronald A, Yin M, Wyatt C. Low risk of Proximal Tubular Dysfunction Associated with Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis in Men and Women. The Journal of Infectious Diseases. PMID 27029778 DOI: 10.1093/Infdis/Jiw125 |
0.629 |
|
| 2016 |
Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM. An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26918545 DOI: 10.1097/Qai.0000000000000974 |
0.697 |
|
| 2016 |
Mugwanya KK, Wyatt C, Celum C, Donnell D, Kiarie J, Ronald A, Baeten JM. Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999). 71: 374-80. PMID 26914909 DOI: 10.1097/Qai.0000000000000868 |
0.59 |
|
| 2016 |
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, et al. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. The New England Journal of Medicine. PMID 26900902 DOI: 10.1097/01.Ogx.0000489577.60775.40 |
0.681 |
|
| 2016 |
Ngure K, Heffron R, Curran K, Vusha S, Ngutu M, Mugo N, Celum C, Baeten JM. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation. Aids Patient Care and Stds. 30: 78-83. PMID 26836236 DOI: 10.1089/Apc.2015.0259 |
0.813 |
|
| 2016 |
Musinguzi N, Muganzi CD, Boum Y, Ronald A, Marzinke MA, Hendrix CW, Celum C, Baeten J, Bangsberg DR, Haberer JE. Comparison of subjective and objective adherence measures for pre-exposure prophylaxis against HIV infection among serodiscordant couples in East Africa. Aids (London, England). PMID 26785125 DOI: 10.1097/Qad.0000000000001024 |
0.565 |
|
| 2016 |
Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya. Aids Care. 1-7. PMID 26754017 DOI: 10.1080/09540121.2015.1131972 |
0.87 |
|
| 2016 |
Weis JF, Baeten JM, McCoy CO, Warth C, Donnell D, Thomas KK, Hendrix CW, Marzinke MA, Mugo N, Iv FA, Celum C, Lehman DA. Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation. Aids (London, England). 30: 31-5. PMID 26731753 DOI: 10.1097/Qad.0000000000000915 |
0.394 |
|
| 2016 |
Mujugira A, Celum C, Tappero JW, Ronald A, Mugo N, Baeten JM. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships. Aids Research and Human Retroviruses. 32: 148-54. PMID 26670218 DOI: 10.1089/Aid.2015.0296 |
0.636 |
|
| 2016 |
Mugwanya KK, Baeten JM. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. Expert Opinion On Drug Safety. 15: 265-73. PMID 26634852 DOI: 10.1517/14740338.2016.1128412 |
0.656 |
|
| 2016 |
Baeten J, McCormack S. Welcome to the preexposure prophylaxis revolution. Current Opinion in Hiv and Aids. 11: 1-2. PMID 26633637 DOI: 10.1097/Coh.0000000000000225 |
0.486 |
|
| 2016 |
Dhanireddy S, Baeten JM. Tenofovir alafenamide for HIV: time to switch? The Lancet. Infectious Diseases. 16: 3-5. PMID 26538524 DOI: 10.1016/S1473-3099(15)00412-0 |
0.646 |
|
| 2016 |
Mugwanya KK, Wyatt C, Celum C, Donnell D, Kiarie J, Ronald A, Baeten JM. Reversibility of glomerular renal function decline in HIV-uninfected men and women discontinuing emtricitabine-tenofovir disoproxil fumarate pre-exposure prophylaxis Journal of Acquired Immune Deficiency Syndromes. 71: 374-380. DOI: 10.1097/QAI.0000000000000868 |
0.487 |
|
| 2016 |
Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 1-7. DOI: 10.1080/09540121.2015.1131972 |
0.749 |
|
| 2016 |
Ying R, Sharma M, Celum C, Baeten JM, van Rooyen H, Hughes JP, Garnett G, Barnabas RV. Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: A mathematical modelling analysis The Lancet Hiv. DOI: 10.1016/S2352-3018(16)30009-1 |
0.589 |
|
| 2016 |
Barnabas RV, van Rooyen H, Tumwesigye E, Brantley J, Baeten JM, van Heerden A, Turyamureeba B, Joseph P, Krows M, Thomas KK, Schaafsma TT, Hughes JP, Celum C. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: A multisite, open-label, randomised controlled trial in South Africa and Uganda The Lancet Hiv. DOI: 10.1016/S2352-3018(16)00020-5 |
0.416 |
|
| 2015 |
Heffron R, Cohen CR, Ngure K, Bukusi E, Were E, Kiarie J, Mugo N, Celum C, Baeten JM. A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy. Plos One. 10: e0145515. PMID 26720412 DOI: 10.1371/Journal.Pone.0145515 |
0.785 |
|
| 2015 |
Fife KH, Mugwanya K, Thomas KK, Baeten JM, Celum C, Bukusi E, de Bruyn G, Mujugira A, Vwalika B, Wald A, Lingappa JR. Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals. The Journal of Infectious Diseases. PMID 26704611 DOI: 10.1093/Infdis/Jiv765 |
0.568 |
|
| 2015 |
Pattacini L, Baeten JM, Thomas KK, Fluharty TR, Murnane PM, Donnell D, Bukusi E, Ronald A, Mugo N, Lingappa JR, Celum C, McElrath MJ, Lund JM. Regulatory T-cell activity but not conventional HIV-specific T-cell responses are associated with protection from HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26656786 DOI: 10.1097/Qai.0000000000000919 |
0.635 |
|
| 2015 |
Pyra M, Heffron R, Mugo NR, Nanda K, Thomas KK, Celum C, Kourtis AP, Were E, Rees H, Bukusi E, Baeten JM. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. Aids (London, England). 29: 2353-9. PMID 26544706 DOI: 10.1097/Qad.0000000000000827 |
0.707 |
|
| 2015 |
Murnane PM, Brown ER, Donnell D, Coley RY, Mugo N, Mujugira A, Celum C, Baeten JM. Estimating Efficacy in a Randomized Trial With Product Nonadherence: Application of Multiple Methods to a Trial of Preexposure Prophylaxis for HIV Prevention. American Journal of Epidemiology. 182: 848-56. PMID 26487343 DOI: 10.1093/Aje/Kwv202 |
0.374 |
|
| 2015 |
Morrison S, John-Stewart G, Egessa JJ, Mubezi S, Kusemererwa S, Bii DK, Bulya N, Mugume F, Campbell JD, Wangisi J, Bukusi EA, Celum C, Baeten JM. Rapid Antiretroviral Therapy Initiation for Women in an HIV-1 Prevention Clinical Trial Experiencing Primary HIV-1 Infection during Pregnancy or Breastfeeding. Plos One. 10: e0140773. PMID 26469986 DOI: 10.1371/Journal.Pone.0140773 |
0.669 |
|
| 2015 |
Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women. Current Opinion in Hiv and Aids. PMID 26417954 DOI: 10.1097/Coh.0000000000000207 |
0.751 |
|
| 2015 |
Pintye J, Ngure K, Curran K, Vusha S, Mugo N, Celum C, Baeten JM, Heffron R. Fertility Decision-Making Among Kenyan HIV-Serodiscordant Couples Who Recently Conceived: Implications for Safer Conception Planning. Aids Patient Care and Stds. 29: 510-6. PMID 26301703 DOI: 10.1089/Apc.2015.0063 |
0.865 |
|
| 2015 |
Khanna AS, Roberts ST, Cassels S, Ying R, John-Stewart G, Goodreau SM, Baeten JM, Murnane PM, Celum C, Barnabas RV. Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis. Plos One. 10: e0134271. PMID 26262889 DOI: 10.1371/Journal.Pone.0134271 |
0.674 |
|
| 2015 |
Celum CL, Delany-Moretlwe S, McConnell M, van Rooyen H, Bekker LG, Kurth A, Bukusi E, Desmond C, Morton J, Baeten JM. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. Journal of the International Aids Society. 18: 20227. PMID 26198350 DOI: 10.7448/Ias.18.4.20227 |
0.692 |
|
| 2015 |
Ying R, Sharma M, Heffron R, Celum CL, Baeten JM, Katabira E, Bulya N, Barnabas RV. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda. Journal of the International Aids Society. 18: 20013. PMID 26198348 DOI: 10.7448/Ias.18.4.20013 |
0.798 |
|
| 2015 |
Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, et al. Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study. The Lancet Hiv. 2: e279-e287. PMID 26155597 DOI: 10.1016/S2352-3018(15)00058-2 |
0.639 |
|
| 2015 |
Barnabas RV, Baeten JM, Lingappa JR, Thomas KK, Hughes JP, Mugo NR, Delany-Moretlwe S, Gray G, Rees H, Mujugira A, Ronald A, Stevens W, Kapiga S, Wald A, Celum C, et al. Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial. The Journal of Infectious Diseases. PMID 26142452 DOI: 10.1093/Infdis/Jiv318 |
0.619 |
|
| 2015 |
Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Graham SM, Shafi J, Kiarie J, Overbaugh J, McClelland RS. Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012. Aids (London, England). 29: 1077-85. PMID 26125141 DOI: 10.1097/Qad.0000000000000646 |
0.629 |
|
| 2015 |
Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P, Caceres C, O'Reilly K. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. Aids (London, England). 29: 1277-85. PMID 26103095 DOI: 10.1097/Qad.0000000000000647 |
0.851 |
|
| 2015 |
Baeten JM, Heffron R. Contraception and sexually transmitted infections: risks and benefits, hypotheses and evidence. The Lancet. Global Health. 3: e430-1. PMID 26094163 DOI: 10.1016/S2214-109X(15)00085-6 |
0.652 |
|
| 2015 |
Palanee-Phillips T, Schwartz K, Brown ER, Govender V, Mgodi N, Kiweewa FM, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Naidoo S, ... ... Baeten J, et al. Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention. Plos One. 10: e0128857. PMID 26061040 DOI: 10.1371/Journal.Pone.0128857 |
0.598 |
|
| 2015 |
Wyatt C, Baeten JM. Tenofovir alafenamide for HIV infection: is less more? Lancet (London, England). 385: 2559-60. PMID 25890672 DOI: 10.1016/S0140-6736(15)60725-5 |
0.657 |
|
| 2015 |
Ndase P, Celum C, Kidoguchi L, Ronald A, Fife KH, Bukusi E, Donnell D, Baeten JM. Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. Plos One. 10: e0123005. PMID 25885664 DOI: 10.1371/Journal.Pone.0123005 |
0.704 |
|
| 2015 |
Smith JA, Sharma M, Levin C, Baeten JM, van Rooyen H, Celum C, Hallett TB, Barnabas RV. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. The Lancet. Hiv. 2: e159-e168. PMID 25844394 DOI: 10.1016/S2352-3018(15)00016-8 |
0.489 |
|
| 2015 |
Jewell BL, Cremin I, Pickles M, Celum C, Baeten JM, Delany-Moretlwe S, Hallett TB. Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa. Plos One. 10: e0115511. PMID 25616135 DOI: 10.1371/Journal.Pone.0115511 |
0.67 |
|
| 2015 |
Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. Plos Medicine. 12: e1001778. PMID 25612136 DOI: 10.1371/Journal.Pmed.1001778 |
0.824 |
|
| 2015 |
Lehman DA, Baeten JM, McCoy CO, Weis JF, Peterson D, Mbara G, Donnell D, Thomas KK, Hendrix CW, Marzinke MA, Frenkel L, Ndase P, Mugo NR, Celum C, Overbaugh J, et al. Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis. The Journal of Infectious Diseases. 211: 1211-8. PMID 25587020 DOI: 10.1093/Infdis/Jiu677 |
0.577 |
|
| 2015 |
Mugwanya KK, Wyatt C, Celum C, Donnell D, Mugo NR, Tappero J, Kiarie J, Ronald A, Baeten JM. Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial. Jama Internal Medicine. 175: 246-54. PMID 25531343 DOI: 10.1001/Jamainternmed.2014.6786 |
0.694 |
|
| 2015 |
Pattacini L, Murnane PM, Baeten JM, Fluharty TR, Thomas KK, Bukusi E, Katabira E, Mugo N, Donnell D, Lingappa JR, Celum C, Marzinke M, McElrath MJ, Lund JM. Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons. The Journal of Infectious Diseases. 211: 1943-52. PMID 25520426 DOI: 10.1093/Infdis/Jiu815 |
0.687 |
|
| 2015 |
Mackelprang RD, Carrington M, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, Fife K, Campbell MS, Kapiga S, Gao X, Mullins JI, Lingappa JR. Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa. Journal of Virology. 89: 2104-11. PMID 25473042 DOI: 10.1128/Jvi.01573-14 |
0.587 |
|
| 2015 |
Kahle EM, Bolton M, Hughes JP, Donnell D, Celum C, Lingappa JR, Ronald A, Cohen CR, de Bruyn G, Fong Y, Katabira E, McElrath MJ, Baeten JM. Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples. The Journal of Infectious Diseases. 211: 1451-60. PMID 25389306 DOI: 10.1093/Infdis/Jiu621 |
0.851 |
|
| 2015 |
Ware NC, Pisarski EE, Haberer JE, Wyatt MA, Tumwesigye E, Baeten JM, Celum CL, Bangsberg DR. Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study. Aids and Behavior. 19: 811-20. PMID 25267114 DOI: 10.1007/S10461-014-0899-4 |
0.611 |
|
| 2015 |
Ying R, Sharma M, Heffron R, Celum CL, Baeten JM, Katabira E, Bulya N, Barnabas RV. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda Journal of the International Aids Society. 18. DOI: 10.7448/IAS.18.4.20013 |
0.511 |
|
| 2015 |
Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, et al. Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: A prospective cohort study The Lancet Hiv. DOI: 10.1016/S2352-3018(15)00058-2 |
0.573 |
|
| 2014 |
Barnabas RV, van Rooyen H, Tumwesigye E, Murnane PM, Baeten JM, Humphries H, Turyamureeba B, Joseph P, Krows M, Hughes JP, Celum C. Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study. The Lancet. Hiv. 1: e68-e76. PMID 25601912 DOI: 10.1016/S2352-3018(14)70024-4 |
0.699 |
|
| 2014 |
Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. Aids (London, England). 28: 2771-6. PMID 25493602 DOI: 10.1097/Qad.0000000000000493 |
0.807 |
|
| 2014 |
Pintye J, Baeten JM, Manhart LE, Celum C, Ronald A, Mugo N, Mujugira A, Cohen C, Were E, Bukusi E, Kiarie J, Heffron R. Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples. The Lancet. Global Health. 2: e664-71. PMID 25442691 DOI: 10.1016/S2214-109X(14)70315-8 |
0.705 |
|
| 2014 |
Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, et al. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. The Lancet. Infectious Diseases. 14: 1055-64. PMID 25300863 DOI: 10.1016/S1473-3099(14)70937-5 |
0.609 |
|
| 2014 |
Were EO, Heffron R, Mugo NR, Celum C, Mujugira A, Bukusi EA, Baeten JM. Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men. Aids (London, England). 28: 1977-82. PMID 25259704 DOI: 10.1097/Qad.0000000000000313 |
0.785 |
|
| 2014 |
Baeten J, Baron D, Cates W, Celum C, Chipato T, Chombes S, Donnell D, Gichangi, Hofmeyr J, Morrison C, Mugo N, Nanda K, Palanee T, Steyn P, Taylor D, et al. DMPA and HIV: why we need a trial. Contraception. 90: 354. PMID 25183263 DOI: 10.1016/J.Contraception.2014.08.007 |
0.668 |
|
| 2014 |
Matthews LT, Heffron R, Mugo NR, Cohen CR, Hendrix CW, Celum C, Bangsberg DR, Baeten JM. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 91-7. PMID 25118795 DOI: 10.1097/Qai.0000000000000246 |
0.767 |
|
| 2014 |
Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial. Jama. 312: 362-71. PMID 25038355 DOI: 10.1001/Jama.2014.8735 |
0.718 |
|
| 2014 |
Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM. Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial. Annals of Internal Medicine. 161: 11-9. PMID 24979446 DOI: 10.7326/M13-2471 |
0.63 |
|
| 2014 |
Roberts ST, Heffron R, Ngure K, Celum C, Kurth A, Curran K, Mugo N, Baeten JM. Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples. Aids and Behavior. 18: 1701-11. PMID 24871870 DOI: 10.1007/S10461-014-0804-1 |
0.868 |
|
| 2014 |
Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, ... Baeten JM, et al. An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 522-9. PMID 24853311 DOI: 10.1097/Qai.0000000000000212 |
0.617 |
|
| 2014 |
Ndase P, Celum C, Campbell J, Bukusi E, Kiarie J, Katabira E, Mugo N, Tumwesigye E, Wangisi J, Were E, Brantley J, Donnell D, Baeten JM. Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 206-12. PMID 24828268 DOI: 10.1097/Qai.0000000000000141 |
0.619 |
|
| 2014 |
Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, Bukusi EA, Tumwesigye E, Baeten JM. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 436-42. PMID 24798765 DOI: 10.1097/Qai.0000000000000192 |
0.707 |
|
| 2014 |
Murnane PM, Heffron R, Ronald A, Bukusi EA, Donnell D, Mugo NR, Were E, Mujugira A, Kiarie J, Celum C, Baeten JM. Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception. Aids (London, England). 28: 1825-30. PMID 24785951 DOI: 10.1097/Qad.0000000000000290 |
0.817 |
|
| 2014 |
Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 340-8. PMID 24784763 DOI: 10.1097/Qai.0000000000000172 |
0.663 |
|
| 2014 |
Ngure K, Baeten JM, Mugo N, Curran K, Vusha S, Heffron R, Celum C, Shell-Duncan B. My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya. Aids Care. 26: 1283-7. PMID 24779445 DOI: 10.1080/09540121.2014.911808 |
0.877 |
|
| 2014 |
Baeten JM, Heffron R. Pre-exposure prophylaxis to intensify the fight against HIV. The Lancet. Infectious Diseases. 14: 443-5. PMID 24613083 DOI: 10.1016/S1473-3099(14)70070-2 |
0.781 |
|
| 2014 |
Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, Essex M, De Bruyn G, Wald A, Donnell D, John-Stewart G, Delany-Moretlwe S, Mugo NR, Farquhar C, Lingappa JR, et al. Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study Journal of Acquired Immune Deficiency Syndromes. 65: e90-e94. PMID 24442233 DOI: 10.1097/Qai.0B013E3182A2Db02 |
0.846 |
|
| 2014 |
Heffron R, Donnell D, Kiarie J, Rees H, Ngure K, Mugo N, Were E, Celum C, Baeten JM. A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 231-6. PMID 24442226 DOI: 10.1097/Qai.0000000000000013 |
0.757 |
|
| 2014 |
Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Ondondo R, Mujugira A, Fife K, Mugo N, Kapiga S, Mullins JI, Baeten JM. HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples. Aids (London, England). 28: 235-43. PMID 24413311 DOI: 10.1097/Qad.0000000000000024 |
0.839 |
|
| 2014 |
Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, Celum C, Baeten JM. 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy. Aids (London, England). 28: 227-33. PMID 24413310 DOI: 10.1097/Qad.0000000000000025 |
0.873 |
|
| 2014 |
Lehman DA, Ronen K, Blish CA, Baeten JM, Jalalian-Lechak Z, Jaoko W, Mandaliya K, Richardson BA, McClelland RS, Overbaugh J. Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 135-9. PMID 24413043 DOI: 10.1097/Qai.0000000000000104 |
0.606 |
|
| 2014 |
Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Jaoko W, Shafi J, Kiarie J, McClelland RS. Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis. The Journal of Infectious Diseases. 209: 1023-7. PMID 24273042 DOI: 10.1093/Infdis/Jit634 |
0.445 |
|
| 2013 |
Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK, Baeten JM. Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. Aids (London, England). 27: 2155-60. PMID 24384592 DOI: 10.1097/Qad.0B013E3283629037 |
0.844 |
|
| 2013 |
Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, Katabira E, Ngure K, Baeten JM. Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. The Lancet. Infectious Diseases. 13: 1021-8. PMID 24139639 DOI: 10.1016/S1473-3099(13)70226-3 |
0.686 |
|
| 2013 |
Wilcher R, Cates W, Baeten JM. Family planning and HIV: two steps forward.... Aids (London, England). 27: S1-4. PMID 24088675 DOI: 10.1097/Qad.0000000000000064 |
0.618 |
|
| 2013 |
Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. Plos Medicine. 10: e1001511. PMID 24058300 DOI: 10.1371/Journal.Pmed.1001511 |
0.599 |
|
| 2013 |
Jacob ST, Pavlinac PB, Nakiyingi L, Banura P, Baeten JM, Morgan K, Magaret A, Manabe Y, Reynolds SJ, Liles WC, Wald A, Joloba ML, Mayanja-Kizza H, Scheld WM. Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. Plos One. 8: e70305. PMID 23940557 DOI: 10.1371/Journal.Pone.0070305 |
0.433 |
|
| 2013 |
Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA, Karita E, Kapiga S, Corey L, Wald A. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. The Journal of Infectious Diseases. 208: 1366-74. PMID 23901094 DOI: 10.1093/Infdis/Jit333 |
0.521 |
|
| 2013 |
Pattacini L, Murnane PM, Kahle EM, Bolton MJ, Delrow JJ, Lingappa JR, Katabira E, Donnell D, McElrath MJ, Baeten JM, Lund JM. Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. Aids Research and Human Retroviruses. 29: 1321-9. PMID 23815575 DOI: 10.1089/Aid.2013.0075 |
0.774 |
|
| 2013 |
Baisley K, Baeten JM, Hughes JP, Donnell DJ, Wang J, Hayes R, Watson Jones D, Celum C. Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. Aids and Behavior. 17: 3108-19. PMID 23801018 DOI: 10.1007/S10461-013-0542-9 |
0.562 |
|
| 2013 |
Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, Van Rooyen H, Buchbinder S. Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations. Journal of Acquired Immune Deficiency Syndromes (1999). 63: S213-20. PMID 23764638 DOI: 10.1097/Qai.0B013E3182986F3A |
0.699 |
|
| 2013 |
Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? Journal of Acquired Immune Deficiency Syndromes (1999). 63: S122-9. PMID 23764623 DOI: 10.1097/Qai.0B013E3182986F69 |
0.721 |
|
| 2013 |
Campbell MS, Kahle EM, Baeten JM. Reply to Neogi et al. The Journal of Infectious Diseases. 208: 867-8. PMID 23757336 DOI: 10.1093/Infdis/Jit259 |
0.788 |
|
| 2013 |
van Rooyen H, Barnabas RV, Baeten JM, Phakathi Z, Joseph P, Krows M, Hong T, Murnane PM, Hughes J, Celum C. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 64: e1-8. PMID 23714740 DOI: 10.1097/Qai.0B013E31829B567D |
0.686 |
|
| 2013 |
Curran K, Mugo NR, Kurth A, Ngure K, Heffron R, Donnell D, Celum C, Baeten JM. Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women. Aids and Behavior. 17: 2977-85. PMID 23695519 DOI: 10.1007/S10461-013-0510-4 |
0.807 |
|
| 2013 |
Mujugira A, Heffron R, Celum C, Mugo N, Nakku-Joloba E, Baeten JM. Fertility intentions and interest in early antiretroviral therapy among East African HIV-1-infected individuals in serodiscordant partnerships. Journal of Acquired Immune Deficiency Syndromes (1999). 63: e33-5. PMID 23574927 DOI: 10.1097/Qai.0B013E318288Bb32 |
0.824 |
|
| 2013 |
Celum C, Hallett TB, Baeten JM. HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact. The Journal of Infectious Diseases. 208: 189-91. PMID 23570851 DOI: 10.1093/Infdis/Jit154 |
0.69 |
|
| 2013 |
Perti T, Saracino M, Baeten JM, Johnston C, Diem K, Ocbamichael N, Huang ML, Selke S, Magaret A, Corey L, Wald A. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 201-8. PMID 23542637 DOI: 10.1097/Qai.0B013E3182928Eea |
0.629 |
|
| 2013 |
Baeten JM, Grant R. Use of antiretrovirals for HIV prevention: what do we know and what don't we know? Current Hiv/Aids Reports. 10: 142-51. PMID 23494772 DOI: 10.1007/S11904-013-0157-9 |
0.727 |
|
| 2013 |
Masese L, Baeten JM, Richardson BA, Deya R, Kabare E, Bukusi E, John-Stewart G, Jaoko W, McClelland RS. Incidence and correlates of Chlamydia trachomatis infection in a high-risk cohort of Kenyan women. Sexually Transmitted Diseases. 40: 221-5. PMID 23407467 DOI: 10.1097/Olq.0B013E318272Fe45 |
0.35 |
|
| 2013 |
Celum C, Baeten JM. Serodiscordancy and HIV prevention in sub-Saharan Africa. Lancet (London, England). 381: 1519-21. PMID 23391463 DOI: 10.1016/S0140-6736(13)60147-6 |
0.656 |
|
| 2013 |
Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, Barnabas RV, Hallett TB. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. Plos One. 8: e54575. PMID 23372738 DOI: 10.1371/Journal.Pone.0054575 |
0.573 |
|
| 2013 |
Campbell MS, Kahle EM, Celum C, Lingappa JR, Kapiga S, Mujugira A, Mugo NR, Fife KH, Mullins JI, Baeten JM. Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters. The Journal of Infectious Diseases. 207: 1166-70. PMID 23315322 DOI: 10.1093/Infdis/Jit015 |
0.756 |
|
| 2013 |
Baeten JM, Celum C. Antiretroviral preexposure prophylaxis for HIV prevention. The New England Journal of Medicine. 368: 83-4. PMID 23293791 |
0.654 |
|
| 2013 |
Kahle EM, Hughes JP, Lingappa JR, John-Stewart G, Celum C, Nakku-Joloba E, Njuguna S, Mugo N, Bukusi E, Manongi R, Baeten JM. An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 339-47. PMID 23187945 DOI: 10.1097/Qai.0B013E31827E622D |
0.843 |
|
| 2013 |
Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C, Dhanireddy S, Baeten JM. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya. The Journal of Infectious Diseases. 207: 402-10. PMID 23175769 DOI: 10.1093/Infdis/Jis695 |
0.534 |
|
| 2013 |
Heffron R, Mugo N, Ngure K, Celum C, Donnell D, Were E, Rees H, Kiarie J, Baeten JM. Hormonal contraceptive use and risk of HIV-1 disease progression. Aids (London, England). 27: 261-7. PMID 23079806 DOI: 10.1097/Qad.0B013E32835Ad473 |
0.786 |
|
| 2013 |
Lingappa JR, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, de Bruyn G, Fife KH, Campbell MS, Kapiga S, Mullins JI, Celum C. Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters. Aids Research and Human Retroviruses. 29: 164-71. PMID 23061422 DOI: 10.1089/Aid.2012.0206 |
0.687 |
|
| 2013 |
Baeten J, Celum C. Oral antiretroviral chemoprophylaxis: current status. Current Opinion in Hiv and Aids. 7: 514-9. PMID 22964886 DOI: 10.1097/Coh.0B013E3283582D30 |
0.708 |
|
| 2013 |
Donnell DJ, Baeten JM, Hong T, Lingappa JR, Mujugira A, Nakku-Joloba E, Bangsberg D, Celum C. Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence. Aids and Behavior. 17: 632-9. PMID 22869103 DOI: 10.1007/S10461-012-0268-0 |
0.657 |
|
| 2013 |
Jacob ST, Pavlinac PB, Nakiyingi L, Banura P, Baeten JM, Morgan K, Magaret A, Manabe Y, Reynolds SJ, Liles WC, Wald A, Joloba ML, Mayanja-Kizza H, Scheld WM. Correction: Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda–High Frequency, Low Clinical Sand Derivation of a Clinical Prediction Score Plos One. 8. DOI: 10.1371/annotation/0a53f994-bfe2-45db-9dbb-97fdfea023c5 |
0.351 |
|
| 2013 |
Celum C, Morrow R, Donnell D, Hong T, Thomas K, Fife K, Nakku-Joloba E, Mujugira A, Baeten J. P3.370 Daily Oral Emtricitabine/Tenofovir Pre-Exposure Prophylaxis and Prevention of HSV-2 Acquisition Among Heterosexual Men and Women Sexually Transmitted Infections. 89: A265.1-A265. DOI: 10.1136/Sextrans-2013-051184.0823 |
0.67 |
|
| 2013 |
Ying R, Celum C, Baeten J, Murnane P, Hong T, Krows M, Rooyen Hv, Humphries H, Hughes JP, Barnabas R. P3.226 Pre-Exposure Prophylaxis (PrEP) is Estimated to Be a Cost-Effective Addition to Antiretroviral Therapy (ART) For HIV Prevention in a Generalised Epidemic Setting Sexually Transmitted Infections. 89: A219.1-A219. DOI: 10.1136/Sextrans-2013-051184.0683 |
0.671 |
|
| 2013 |
Heffron RA, Donnell D, Mugo N, Celum C, Rees H, Ngure K, Were E, Kiarie J, Baeten JM. P3.200 Effect of Pregnancy on HIV-1 Disease Progression Among Antiretroviral-Naive HIV-1 Infected Women Sexually Transmitted Infections. 89: A210.3-A211. DOI: 10.1136/Sextrans-2013-051184.0657 |
0.693 |
|
| 2013 |
Mugwanya KK, Donnell D, Celum C, Mugo N, Thomas KK, Ngure K, Ndase P, Katabira E, Baeten JM. O11.2 Sexual Behaviour of Heterosexual Men and Women Receiving Antiretroviral Pre-Exposure Prophylaxis For HIV Prevention: Post-Unblinding Analysis of the Partners PrEP Study Sexually Transmitted Infections. 89: A46.2-A46. DOI: 10.1136/Sextrans-2013-051184.0144 |
0.663 |
|
| 2013 |
Baeten J. PL05.1 PrEP & Treatment as Prevention For HIV: Finding the Balance Sexually Transmitted Infections. 89: A4.4-A5. DOI: 10.1136/Sextrans-2013-051184.0012 |
0.721 |
|
| 2013 |
Barnabas R, Ying R, Rooyen Hv, Murnane P, Hughes J, Baeten J, Celum C. Use of HIV viral-load suppression to estimate the effect of community-wide home-based HIV counselling and testing and linkage to antiretroviral therapy on HIV incidence in South Africa: a mathematical modelling analysis The Lancet. 382. DOI: 10.1016/S0140-6736(13)62254-0 |
0.705 |
|
| 2012 |
Tumwebaze H, Tumwesigye E, Baeten JM, Kurth AE, Revall J, Murnane PM, Chang LW, Celum C. Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation. Plos One. 7: e51620. PMID 23272125 DOI: 10.1371/Journal.Pone.0051620 |
0.696 |
|
| 2012 |
Murnane PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, Kiarie J, Wald A, Baeten JM. Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission. Plos One. 7: e51192. PMID 23250272 DOI: 10.1371/Journal.Pone.0051192 |
0.653 |
|
| 2012 |
Celum C, Baeten JM. Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antiviral Therapy. 17: 1483-93. PMID 23221365 DOI: 10.3851/Imp2492 |
0.736 |
|
| 2012 |
de Bruyn G, Magaret A, Baeten JM, Lingappa JR, Ndase P, Celum C, Wald A. Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial. Bmc Infectious Diseases. 12: 277. PMID 23130818 DOI: 10.1186/1471-2334-12-277 |
0.665 |
|
| 2012 |
Baeten J, Celum C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annual Review of Medicine. 64: 219-32. PMID 23020883 DOI: 10.1146/Annurev-Med-050911-163701 |
0.705 |
|
| 2012 |
Mackelprang RD, Baeten JM, Donnell D, Celum C, Farquhar C, de Bruyn G, Essex M, McElrath MJ, Nakku-Joloba E, Lingappa JR. Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. The Journal of Infectious Diseases. 206: 1299-308. PMID 22926009 DOI: 10.1093/Infdis/Jis480 |
0.715 |
|
| 2012 |
Blish CA, McClelland RS, Richardson BA, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J. Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 436-40. PMID 22878424 DOI: 10.1097/Qai.0B013E31826C2Edd |
0.6 |
|
| 2012 |
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England Journal of Medicine. 367: 399-410. PMID 22784037 DOI: 10.1056/Nejmoa1108524 |
0.727 |
|
| 2012 |
Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. Plos Medicine. 9: e1001251. PMID 22745608 DOI: 10.1371/Journal.Pmed.1001251 |
0.723 |
|
| 2012 |
Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K, Baeten JM. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 116-9. PMID 22595872 DOI: 10.1097/Qai.0B013E31825Da73F |
0.895 |
|
| 2012 |
Holte SE, Randolph TW, Ding J, Tien J, McClelland RS, Baeten JM, Overbaugh J. Efficient use of longitudinal CD4 counts and viral load measures in survival analysis. Statistics in Medicine. 31: 2086-97. PMID 22415871 DOI: 10.1002/Sim.5318 |
0.341 |
|
| 2012 |
Curran K, Baeten JM, Coates TJ, Kurth A, Mugo NR, Celum C. HIV-1 prevention for HIV-1 serodiscordant couples. Current Hiv/Aids Reports. 9: 160-70. PMID 22415473 DOI: 10.1007/S11904-012-0114-Z |
0.874 |
|
| 2012 |
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L, Hendrix CW. Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations. Antimicrobial Agents and Chemotherapy. 56: 2777-9. PMID 22330926 DOI: 10.1128/Aac.06160-11 |
0.49 |
|
| 2012 |
Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. Aids Research and Human Retroviruses. 28: 1177-83. PMID 22283149 DOI: 10.1089/Aid.2011.0341 |
0.595 |
|
| 2012 |
Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. Journal of Acquired Immune Deficiency Syndromes (1999). 59: 463-8. PMID 22267018 DOI: 10.1097/Qai.0B013E31824A060B |
0.648 |
|
| 2012 |
Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, Kiarie J, Inambao M, Kilembe W, Farquhar C, Celum C. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. The Journal of Infectious Diseases. 205: 358-65. PMID 22241800 DOI: 10.1093/Infdis/Jir747 |
0.715 |
|
| 2012 |
Baeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A, Celum C. Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial. Sexually Transmitted Diseases. 39: 21-4. PMID 22183840 DOI: 10.1097/Olq.0B013E31823B50C6 |
0.428 |
|
| 2012 |
Ngure K, Heffron R, Mugo NR, Celum C, Cohen CR, Odoyo J, Rees H, Kiarie JN, Were E, Baeten JM. Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships. Aids (London, England). 26: 513-8. PMID 22156966 DOI: 10.1097/Qad.0B013E32834F981C |
0.767 |
|
| 2012 |
Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Current Opinion in Infectious Diseases. 25: 51-7. PMID 22156901 DOI: 10.1097/Qco.0B013E32834Ef5Ef |
0.67 |
|
| 2012 |
Ngure K, Mugo N, Celum C, Baeten JM, Morris M, Olungah O, Olenja J, Tamooh H, Shell-Duncan B. A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. Aids Care. 24: 509-16. PMID 22085306 DOI: 10.1080/09540121.2011.613911 |
0.649 |
|
| 2012 |
Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. The Lancet. Infectious Diseases. 12: 19-26. PMID 21975269 DOI: 10.1016/S1473-3099(11)70247-X |
0.821 |
|
| 2012 |
Ndase P, Celum C, Thomas K, Donnell D, Fife KH, Bukusi E, Delany-Moretlwe S, Baeten JM. Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships. Journal of Acquired Immune Deficiency Syndromes (1999). 59: 65-71. PMID 21963939 DOI: 10.1097/Qai.0B013E318237B864 |
0.711 |
|
| 2012 |
Heffron R, Rees H, Mugo N, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission - Authors' reply The Lancet Infectious Diseases. 12: 510-511. DOI: 10.1016/S1473-3099(12)70153-6 |
0.771 |
|
| 2012 |
Baeten JM. Preexposure prophylaxis reduced HIV-1 spread in serodiscordant heterosexual couples Annals of Internal Medicine. 157. |
0.618 |
|
| 2011 |
Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna K, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A, de Bruyn G, Mullins JI, Nakku-Joloba E, Farquhar C, Essex M, et al. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. Plos One. 6: e28632. PMID 22174851 DOI: 10.1371/Journal.Pone.0028632 |
0.853 |
|
| 2011 |
Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin Í, Delany S, Garnett GP, Gray G, Johnson L, McIntyre J, Rees H, Celum C. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. Plos Medicine. 8: e1001123. PMID 22110407 DOI: 10.1371/Journal.Pmed.1001123 |
0.789 |
|
| 2011 |
Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, et al. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. Plos One. 6: e25828. PMID 21998703 DOI: 10.1371/Journal.Pone.0025828 |
0.726 |
|
| 2011 |
Mugwanya K, Baeten JM, Mugo NR, Irungu E, Ngure K, Celum C. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial. The Journal of Infectious Diseases. 204: 1912-7. PMID 21998479 DOI: 10.1093/Infdis/Jir649 |
0.606 |
|
| 2011 |
Were E, Curran K, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Kiarie J, Bukusi EA, Celum C, Baeten JM. A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples. Aids (London, England). 25: 2009-18. PMID 21811146 DOI: 10.1097/Qad.0B013E32834B005D |
0.856 |
|
| 2011 |
Mugwanya KK, Whalen C, Celum C, Nakku-Joloba E, Katabira E, Baeten JM. Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda. Plos One. 6: e22254. PMID 21799805 DOI: 10.1371/Journal.Pone.0022254 |
0.651 |
|
| 2011 |
Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, Celum C, Kiarie JN, Cohen CR, Kayintekore K, Baeten JM. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. Aids (London, England). 25: 1887-95. PMID 21785321 DOI: 10.1097/Qad.0B013E32834A9338 |
0.817 |
|
| 2011 |
Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, Campbell MS, Mullins JI, Celum C. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Science Translational Medicine. 3: 77ra29. PMID 21471433 DOI: 10.1126/Scitranslmed.3001888 |
0.844 |
|
| 2011 |
Mujugira A, Magaret AS, Baeten JM, Celum C, Lingappa J. Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons. Bmc Research Notes. 4: 64. PMID 21406077 DOI: 10.1186/1756-0500-4-64 |
0.635 |
|
| 2011 |
Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W, Kahle E, Panteleeff D, Baeten JM, McCutchan FE, Albert J, et al. Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. Plos One. 6: e16986. PMID 21399681 DOI: 10.1371/Journal.Pone.0016986 |
0.853 |
|
| 2011 |
Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, Hayes RJ, Baeten JM, Brown J, Delany-Moretlwe S, Kaul R, McGrath N, Morrison C, Myer L, Temmerman M, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. Plos Medicine. 8: e1000416. PMID 21358808 DOI: 10.1371/Journal.Pmed.1000416 |
0.678 |
|
| 2011 |
Mujugira A, Morrow RA, Celum C, Lingappa J, Delany-Moretlwe S, Fife KH, Heffron R, De Bruyn G, Homawoo B, Karita E, Mugo N, Vwalika B, Baeten JM. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sexually Transmitted Infections. 87: 238-41. PMID 21307152 DOI: 10.1136/Sti.2010.047415 |
0.682 |
|
| 2011 |
Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N, Sanchez J, Essex M, Makhema J, Kiarie J, Farquhar C, et al. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons. The Journal of Infectious Diseases. 203: 117-21. PMID 21148504 DOI: 10.1093/Infdis/Jiq013 |
0.686 |
|
| 2011 |
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD, Koblin B, Griffith S, Wald A, Celum C. A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial. Aids and Behavior. 15: 897-904. PMID 21104007 DOI: 10.1007/S10461-010-9853-2 |
0.441 |
|
| 2011 |
Sánchez J, Sal Y Rosas VG, Hughes JP, Baeten JM, Fuchs J, Buchbinder SP, Koblin BA, Casapia M, Ortiz A, Celum C. Male circumcision and risk of HIV acquisition among MSM. Aids (London, England). 25: 519-23. PMID 21099672 DOI: 10.1097/Qad.0B013E328340Fd81 |
0.648 |
|
| 2011 |
Blish CA, Baeten JM. Hormonal contraception and HIV-1 transmission. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 65: 302-7. PMID 21087338 DOI: 10.1111/J.1600-0897.2010.00930.X |
0.729 |
|
| 2011 |
Hallett TB, Alsallaq RA, Baeten JM, Weiss H, Celum C, Gray R, Abu-Raddad L. Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sexually Transmitted Infections. 87: 88-93. PMID 20966458 DOI: 10.1136/Sti.2010.043372 |
0.687 |
|
| 2011 |
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Current Hiv/Aids Reports. 8: 62-72. PMID 20941553 DOI: 10.1007/S11904-010-0063-3 |
0.692 |
|
| 2011 |
Lu Y, Hendrix C, Celum C, Baeten J, Cowan F, Delany-Moretlwe S, Reid S, Hughes J, Wald A, Corey L. LBO-1.1 Acyclovir achieves lower concentration in African HIV-, HSV-2+ women compared to non-African populations, possibly explaining lower herpes suppression Sexually Transmitted Infections. 87: A350-A350. DOI: 10.1136/Sextrans-2011-050119.1 |
0.486 |
|
| 2011 |
Alsallaq R, Baeten J, Hughes J, Abu-Raddad L, Celum C, Hallett T. O1-S06.04 Modelling the effectiveness of combination prevention from a house-to-house HIV testing platform in KwaZulu Natal, South Africa Sexually Transmitted Infections. 87: A36-A36. DOI: 10.1136/Sextrans-2011-050109.34 |
0.696 |
|
| 2011 |
Perti T, Baeten J, Johnston C, Diem K, Ochbamichael N, Huang M, Selke S, Magaret A, Corey L, Wald A. O3-S5.03 High-dose valacyclovir decreases plasma HIV-1 levels more than standard dose acyclovir in HIV-1, HSV-2 positive persons: a randomised, crossover trial Sexually Transmitted Infections. 87: A79-A79. DOI: 10.1136/Sextrans-2011-050109.129 |
0.64 |
|
| 2011 |
Ngure K, Mugo N, Celum C, Baeten J, Morris M, Olungah O, Olenja J, Tamooh H, Shell-Duncan B. P2-S5.01 A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya Sexually Transmitted Infections. 87: A245-A245. DOI: 10.1136/Sextrans-2011-050108.343 |
0.713 |
|
| 2011 |
Ngure K, Baeten J, Lingappa J, Heffron R, Musingila P, Irungu E, Mwaniki P, Mwaniki L, Wamae R, Mburu S, Mugo N. P1-S6.02 Contraceptive discontinuation by rural Kenyan women in HIV discordant partnerships after exiting an HIV prevention trial Sexually Transmitted Infections. 87: A196-A196. DOI: 10.1136/Sextrans-2011-050108.226 |
0.781 |
|
| 2011 |
Mujugira A, Margaret A, Celum C, Lingappa J, Baeten J, Fife K, Bruyn GD, Bukusi E, Corey L, Wald A. P1-S5.25 Acyclovir and transmission of HSV-2 from HSV-2/HIV-1 dually infected persons Sexually Transmitted Infections. 87. DOI: 10.1136/Sextrans-2011-050108.203 |
0.676 |
|
| 2010 |
Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C, Essex M, Mullins JI, Coombs RW, Rees H, Corey L, et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. Plos One. 5: e12598. PMID 20856886 DOI: 10.1371/Journal.Pone.0012598 |
0.688 |
|
| 2010 |
Matthews LT, Baeten JM, Celum C, Bangsberg DR. Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation. Aids (London, England). 24: 1975-82. PMID 20679759 DOI: 10.1097/Qad.0B013E32833Bedeb |
0.709 |
|
| 2010 |
Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J, Baeten JM. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sexually Transmitted Diseases. 37: 621-8. PMID 20601930 DOI: 10.1097/Olq.0B013E3181E1A162 |
0.797 |
|
| 2010 |
Curlin ME, Huang ML, Lu X, Celum CL, Sanchez J, Selke S, Baeten JM, Zuckerman RA, Erdman DD, Corey L. Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men. Plos One. 5: e11321. PMID 20593015 DOI: 10.1371/Journal.Pone.0011321 |
0.651 |
|
| 2010 |
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (London, England). 375: 2092-8. PMID 20537376 DOI: 10.1016/S0140-6736(10)60705-2 |
0.692 |
|
| 2010 |
Mugwanya KK, Baeten JM, Nakku-Joloba E, Katabira E, Celum C, Tisch D, Whalen C. Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda. Aids and Behavior. 14: 1190-7. PMID 20387112 DOI: 10.1007/S10461-010-9696-X |
0.72 |
|
| 2010 |
Baeten JM. Adherence in HIV type 1 prevention trials. The Journal of Infectious Diseases. 201: 1279-81. PMID 20235837 DOI: 10.1086/651697 |
0.648 |
|
| 2010 |
Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, et al. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet. 375: 824-33. PMID 20153888 DOI: 10.1016/S0140-6736(09)62038-9 |
0.64 |
|
| 2010 |
Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. The New England Journal of Medicine. 362: 427-39. PMID 20089951 DOI: 10.1056/Nejmoa0904849 |
0.678 |
|
| 2010 |
Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C. Male circumcision and risk of male-to-female HIV-1 transmission: A multinational prospective study in African HIV-1-serodiscordant couples Aids. 24: 737-744. PMID 20042848 DOI: 10.1097/Qad.0B013E32833616E0 |
0.676 |
|
| 2010 |
Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A, Celum C. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. Journal of Acquired Immune Deficiency Syndromes (1999). 53: 606-13. PMID 19838129 DOI: 10.1097/Qai.0B013E3181Bc4869 |
0.706 |
|
| 2010 |
Baeten JM. New biomedical strategies for HIV-1 prevention in women. Current Infectious Disease Reports. 10: 490-8. PMID 18945391 DOI: 10.1007/s11908-008-0080-1 |
0.618 |
|
| 2009 |
Ngure K, Heffron R, Mugo N, Irungu E, Celum C, Baeten JM. Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. Aids (London, England). 23: S89-95. PMID 20081393 DOI: 10.1097/01.Aids.0000363781.50580.03 |
0.787 |
|
| 2009 |
Graham SM, Masese L, Gitau R, Mwakangalu D, Jaoko W, Ndinya-Achola J, Mandaliya K, Peshu N, Baeten JM, McClelland RS. Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes. 52: 600-603. PMID 19648822 DOI: 10.1097/Qai.0B013E3181B065Cf |
0.518 |
|
| 2009 |
Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland RS, Overbaugh J. Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression. Journal of Virology. 83: 10269-74. PMID 19640996 DOI: 10.1128/Jvi.01149-09 |
0.487 |
|
| 2009 |
Baeten JM, Celum C, Coates TJ. Male circumcision and HIV risks and benefits for women The Lancet. 374: 182-184. PMID 19616704 DOI: 10.1016/S0140-6736(09)61311-8 |
0.586 |
|
| 2009 |
Piantadosi A, Chohan B, Panteleeff D, Baeten JM, Mandaliya K, Ndinya-Achola JO, Overbaugh J. HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response. Aids (London, England). 23: 579-87. PMID 19516110 DOI: 10.1097/Qad.0B013E328328F76E |
0.553 |
|
| 2009 |
Chohan V, Baeten JM, Benki S, Graham SM, Lavreys L, Mandaliya K, Ndinya-Achola JO, Jaoko W, Overbaugh J, McClelland RS. A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya Sexually Transmitted Infections. 85: 489-492. PMID 19457873 DOI: 10.1136/Sti.2009.036103 |
0.607 |
|
| 2009 |
Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret A, Baeten J, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. Plos One. 4: e5272. PMID 19404392 DOI: 10.1371/Journal.Pone.0005272 |
0.866 |
|
| 2009 |
Baeten JM, Hassan WM, Chohan V, Richardson BA, Mandaliya K, Ndinya-Achola JO, Jaoko W, McClelland RS. Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women Sexually Transmitted Infections. 85: 348-353. PMID 19329442 DOI: 10.1136/Sti.2008.035451 |
0.568 |
|
| 2009 |
Curlin M, Celum C, Sanchez J, Selke S, Baeten J, Huang M, Zuckerman R, Lu X, Erdman D, Corey L. P11-17. Intermittent rectal shedding of multiple human adenovirus serotypes among HIV-positive MSM Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P162 |
0.644 |
|
| 2009 |
Lingappa J, Hughes J, Donnel D, Baeten J, Mullins J, Campbell M, Gray G, Essex M, Farquhar C, Rees H, Wald A, Corey L, Celum C. OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission Retrovirology. 6: O12. DOI: 10.1186/1742-4690-6-S3-O12 |
0.675 |
|
| 2009 |
Baeten JM, Celum C, Coates TJ. Male circumcision and risk of HIV in women - Authors' reply The Lancet. 374: 1498. DOI: 10.1016/S0140-6736(09)61899-7 |
0.649 |
|
| 2008 |
Baeten JM, Strick LB, Lucchetti A, Whittington WLH, Sanchez J, Coombs RW, Magaret A, Wald A, Corey L, Celum C. Herpes Simplex Virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: A randomized, placebo-controlled, cross-over trial Journal of Infectious Diseases. 198: 1804-1808. PMID 18928378 DOI: 10.1086/593214 |
0.651 |
|
| 2008 |
McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, Mandaliya K, Kiarie J, Jaoko W, Ndinya-Achola JO, Baeten JM, Kurth AE, Holmes KK. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. The Journal of Infectious Diseases. 197: 1361-8. PMID 18444793 DOI: 10.1086/587490 |
0.526 |
|
| 2008 |
McClelland RS, Richardson BA, Graham SM, Masese LN, Gitau R, Lavreys L, Mandaliya K, Jaoko W, Baeten JM, Ndinya-Achola JO. A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sexually Transmitted Diseases. 35: 617-23. PMID 18418290 DOI: 10.1097/Olq.0B013E31816907Fa |
0.669 |
|
| 2008 |
Manhart LE, Mostad SB, Baeten JM, Astete SG, Mandaliya K, Totten PA. High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. The Journal of Infectious Diseases. 197: 733-6. PMID 18266605 DOI: 10.1086/526501 |
0.624 |
|
| 2008 |
Baeten JM. New biomedical strategies for HIV-1 prevention in women Current Infectious Disease Reports. 10: 490-498. DOI: 10.1007/S11908-008-0080-1 |
0.671 |
|
| 2007 |
Graham SM, Baeten JM, Richardson BA, Wener MH, Lavreys L, Mandaliya K, Ndinya-Achola JO, Overbaugh J, McClelland RS. A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression. Aids Research and Human Retroviruses. 23: 1197-200. PMID 17961104 DOI: 10.1089/Aid.2007.0065 |
0.61 |
|
| 2007 |
Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, Ndinya-Achola JO, Jaoko W, Overbaugh J. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. Aids (London, England). 21: 1771-7. PMID 17690576 DOI: 10.1097/Qad.0B013E328270388A |
0.702 |
|
| 2007 |
Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 360-9. PMID 17599316 DOI: 10.1086/519432 |
0.668 |
|
| 2007 |
Graham SM, Baeten JM, Richardson BA, Bankson DD, Lavreys L, Ndinya-Achola JO, Mandaliya K, Overbaugh J, McClelland RS. Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study. Bmc Infectious Diseases. 7: 63. PMID 17594484 DOI: 10.1186/1471-2334-7-63 |
0.498 |
|
| 2007 |
Baeten JM, McClelland RS, Wener MH, Bankson DD, Lavreys L, Mandaliya K, Bwayo JJ, Kreiss JK. Relationship between markers of HIV-1 disease progression and serum β-carotene concentrations in Kenyan women International Journal of Std and Aids. 18: 202-206. PMID 17362556 DOI: 10.1258/095646207780132541 |
0.603 |
|
| 2007 |
Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, Mandaliya K, Jaoko W, Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. The Journal of Infectious Diseases. 195: 1177-80. PMID 17357054 DOI: 10.1086/512682 |
0.666 |
|
| 2007 |
McClelland RS, Sangaré L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition Journal of Infectious Diseases. 195: 698-702. PMID 17262712 DOI: 10.1086/511278 |
0.687 |
|
| 2007 |
McClelland RS, Ndinya-Achola JO, Baeten JM. Re: "Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: A prospective study of South African women" [3] American Journal of Epidemiology. 165: 474-475. PMID 17158477 DOI: 10.1093/Aje/Kwk101 |
0.612 |
|
| 2006 |
Lavreys L, Baeten JM, Panteleeff DD, Richardson BA, McClelland RS, Chohan V, Mandaliya K, Ndinya-Achola JO, Overbaugh J. High levels of cervical HIV-1 RNA during early HIV-1 infection. Aids (London, England). 20: 2389-90. PMID 17117027 DOI: 10.1097/Qad.0B013E328010F1E7 |
0.663 |
|
| 2006 |
Benki S, McClelland RS, Emery S, Baeten JM, Richardson BA, Lavreys L, Mandaliya K, Overbaugh J. Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters Journal of Clinical Microbiology. 44: 4357-4362. PMID 17050820 DOI: 10.1128/Jcm.01481-06 |
0.691 |
|
| 2006 |
McClelland RS, Hassan WM, Lavreys L, Richardson BA, Mandaliya K, Ndinya-Achola J, Jaoko W, Kurth AE, Baeten JM. HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers. Aids (London, England). 20: 1969-73. PMID 16988519 DOI: 10.1097/01.Aids.0000247119.12327.E6 |
0.587 |
|
| 2006 |
Drain PK, Baeten JM, Overbaugh J, Wener MH, Bankson DD, Lavreys L, Mandaliya K, Ndinya-Achola JO, McClelland RS. Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women Bmc Infectious Diseases. 6. PMID 16712720 DOI: 10.1186/1471-2334-6-85 |
0.464 |
|
| 2006 |
Baeten JM, Wener MH, Bankson DD, Lavreys L, Richardson BA, Mandaliya K, Bwayo JJ, McClelland RS. HIV-1 infection alters the retinol-binding protein:transthyretin ratio even in the absence of the acute phase response Journal of Nutrition. 136: 1624-1629. PMID 16702331 DOI: 10.1093/Jn/136.6.1624 |
0.654 |
|
| 2006 |
McClelland RS, Baeten JM, Richardson BA, Lavreys L, Emery S, Mandaliya K, Ndinya-Achola JO, Overbaugh J. A comparison of genital HIV-1 shedding and sexual risk behavior among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines Journal of Acquired Immune Deficiency Syndromes. 41: 611-615. PMID 16652035 DOI: 10.1097/01.Qai.0000191284.62707.B7 |
0.67 |
|
| 2006 |
Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, Richardson BA, Mandaliya K, Ndinya-Achola JO, Overbaugh J. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women Clinical Infectious Diseases. 42: 1333-1339. PMID 16586394 DOI: 10.1086/503258 |
0.667 |
|
| Show low-probability matches. |